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ABSTRACT
As a cost-efficient alternative to cohort design, case-control design is widely used in
epidemiological studies. The primary analysis of the case-control studies focuses on the
relationship between disease status and the potential risk factors, while the secondary anal-
ysis lies in analyzing the interrelationship between risk factors. The dissertation considers
three semiparametric models arose in primary and ki secondary analysis of case-control
studies and develops novel semiparametric estimators with great estimation efficiency.
We first investigate a special primary analysis problem, the gene-environment inter-
action model under independence assumption. While all existing approaches that exploit
gene-environment independence assumption rely on a rare disease assumption or/and a
distributional assumption on the genetic variable, we allow the disease rate and the distri-
butions of the genetic and environmental variables in the underlying source population to
be unknown. Under such a flexible semiparametric model, we derive the semiparametric
efficient estimator and show that it outperformed the prospective logistic regression, the
standard approach in primary analysis, through various numerical illustrations.
In the secondary conditional mean regression model, we analyze the interrelationship
between covariates while only a conditional mean model is specified. Due to the unknown
error distribution and the case-control nature of the data, semiparametric efficient estima-
tion requires multivariate nonparametric regression on various quantities, which meets the
curse of dimensionality as the dimension of covariates increases. We bypass this problem
by devising a dimension reduction approach. The resulting estimator is robust against the
misspecification of the regression error distribution and it shows great efficiency gain over
several existing methods.
Lastly, we consider a secondary conditional quantile regression problem, which is a
ii
more preferable model in epidemiology when high or low values in the population are
associated with high risks. Under a semiparametric framework that allows the covariates
distribution to be nonparametric, we derive a class of consistent semiparametric estimators
and spot the efficient member. The resulting estimator dominates the weighted estimating
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3.1 Mammographic density data in Section 3.6. The left plot is the kernel den-
sity estimate (solid black line) of the residuals from a linear fit on the con-
trols, with an overlaid normal density (dashed blue line). The right plot is
the LOWESS smoother of fitted values versus the square roots of absolute
values of residuals: the fact that it is flat indicates little heteroscedasticity. 44
4.1 Artificial example discussed in Section 4.2.1. The solid black line is the
relationship between covariate X and secondary outcome Y in the under-
lying source population; the dashed blue line is the relationship under the
case-control context; the dashed red line is the regression function among
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1. INTRODUCTION
1.1 General Semiparametric Framework
Parametric regression, such as generalized linear models, attains great parsimony and
efficiency but only works for well-specified model, while nonparametric regression main-
tains substantial model flexibility at the price of exploded computational cost and reduced
efficiency. In contrast, semiparametric regression is an integration of parametric and non-
parametric regression, where the model parameter can be split into a finite-dimensional
parameter of interest, which represents simple but essential features that may be extracted
from complex data sets, and an infinite-dimensional nuisance parameter, which denotes the
intricate but unimportant details that can be neglected. It allows us to achieve a balance
between estimation efficiency and model flexibility by modeling the finite-dimensional
parameter parametrically and the infinite-dimensional nuisance parameter nonparametri-
cally. A common semiparametric model is linear regression with unspecified error dis-
tribution, where the interest lies in estimating the regression coefficients with the error
distribution being treated as a nuisance parameter. When implemented properly, semi-
parametric regression can be a prominent tool in solving complex problems arised from
epidemiology, psycology, and various other scientific fields.
SupposeX1, · · · ,Xn are independent, and identically distributed (i.i.d.) random vari-
ables taken from a collection of distributions {Pω : ω ∈ Ω}, indexed by a parameter
ω. In a general semiparametric model, ω consists of a p−dimensional parameter θ and
an infinite-dimensional nuisance parameter η, i.e., ω = (θ,η). Semiparametric theories
aim at finding consistent and ideally efficient estimator for θ. In this dissertation, we
restrict ourselves to regular semiparametric estimators, namely regular asymptotically lin-
ear (RAL) estimators first introduced by Newey (1990). Each RAL estimator θ̂ can be
1
uniquely identified by an influence function φ(X;θ,η), i.e., a mean-zero p-dimensional
random function with finite and positive-definite variance, through
√




Subsequently, the asymptotic property of θ̂ can be uniquely characterized by its influence
function. Specifically,
√
n(θ̂ − θ)→ Normal[0, cov{φ(X)}].
Hence, the problem of finding the efficient semiparametric estimator of θ is equivalent to
determing the influence function with smallest variance.
Bickel et al. (1993) and Tsiatis (2007) formulate the above semiparametric problem
using a geometric approach, considering a Hilbert space H that consists of of all p-
dimensional measurable functions with mean zero and finite variance and defining the
inner product of two arbitrary functions in H to be their covariance. The Hilbert space
H can be decomposed into a so-called nuisance tangent space Λ and its the orthogonal
complement Λ⊥. All valid influence functions must fall into the orthogonal space Λ⊥ and
the most efficient influence function can be obtained by projecting the score function, de-
fined as the derivative of the log-likelihood with respect to θ, onto Λ⊥. The score function,
if scaled properly, is a valid influence function. Projecting the score function onto Λ⊥ is
conceptually a procedure of removing the greatest posssible variability due to the nuisance
parameter η. Although the general methodology of this geometric approach is standard
and intuitive, the derivation of the nuisance tangent space Λ and the projection of score
function onto the orthogonal space Λ⊥ can be highly mathematically involved depending
on the specific problems.
2
This dissertation is dedicated to develop semiparametric (locally) efficient estimators
in primary and secondary analysis of case-control studies. Due to its special sampling
scheme, case-control samples are not i.i.d. samples taken from the underlying source pop-
ulation. Thus the direct application of the above geometric approach is prohibited. To con-
quer this problem, we adopt the hypothetical population framework by Ma (2010). Such
a hypothetical population has the same disease to non-disease ratio as the case-control
sample, and it allows us to treat case-control samples as i.i.d. samples taken from this hy-
pothetical population. The validity of the hypothetical population is discussed thoroughly
in Ma (2010).
1.2 Primary and Secondary Analysis in Case-Control Studies
Case-control studies are popular tools in investigating risk factors associated with vari-
ous uncommon diseases, such as cancer and myocardial infarction. Typically, a population-
based case-control study employs a random sample of cases (diseased subjects) and a
separate random sample of controls (non-diseased subjects). It also collects covariate in-
formation on the exposure of interest and other risk factors. As a result, the case-control
samples are no longer representative samples of the underlying source populaiton. The
primary task of case-control studies lies in understanding the relationship between disease
status and covariates, usually via a prospective logistic regression analysis, which gives
an efficient estimator of all parameters except the intercept, under the conditions that the
disease rate is unknown and no parametric model for the predictors is available in the
underlying source population (Prentice and Pyke, 1979).
In Section 2, we consider a special primary model, i.e., the gene-environment inter-
action model under gene-environment independence assumption. With the independence
assumption on genetic and environmental variables, the prospective logistic regression
is still consistent but no more efficient. All other existing approaches that exploit gene-
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environment independence assumption rely on a rare disease assumption or/and a distribu-
tional assumption on the genetic variables such as the genetic variable is discrete and takes
finitely many values. Although the resulting estimators display appealing performances in
terms of efficiency, they are not suitable for more general settings. We relax both as-
sumptions. We construct a semiparametric estimator in case-control studies exploiting
gene-environment independence, while the distributions of genetic susceptibility and en-
vironmental exposures are both unspecified and the disease rate is assumed unknown and
is not required to be close to zero. The resulting estimator is semiparametric efficient
and its superiority over prospective logistic regression, the usual analysis in case-control
studies, is demonstrated in various numerical illustrations.
Recently, there has been considerable interest in using case-control data for a sec-
ondary analysis, namely examining the interrelationship between covariates, say Y and
X. As the case-control data is not a random sample from the underlying source popula-
tion, which we refer to as true population throughout the paper, the relationship between
covariates Y and X in the secondary analysis under the case-control context can be very
different from the relationship in the true population. Hence, simply regressing Y on X
and ignoring the case-control sampling scheme can be grossly misleading.
In Section 3, we examine the secondary analysis problem when multiple covariates are
available, while only a regression mean model between X and Y is specified. Despite the
completely parametric modeling of the regression mean function, the case-control nature
of the data requires special treatment and semiparametric efficient estimation generates
various nonparametric estimation problems with multivariate covariates. We devise a di-
mension reduction approach that fits with the specified primary and secondary models in
the original problem setting, and use reweighting to adjust for the case-control nature of
the data, even when the disease rate in the source population is unknown. The resulting
estimator is both locally efficient and robust against the misspecification of the regression
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error distribution, which can be heteroscedastic as well as non-Gaussian. We demonstrate
the advantage of our method over several existing methods, both analytically and numeri-
cally.
In Section 4, we consider the secondary analysis where the association betweenX and
Y is specified by a conditional quantile regression model, becuase quantiel regression is
often preferable in epidemiology, especially when the interest lies in studying high or low
values of a population. We approach the secondary quantile regression problem from a
semiparametric perspective, allowing the covariates distribution to be completely unspec-
ified. The problem is identifiable excluding a few special cases. We derive a class of
consistent semiparametric estimators and spot the efficient member. The implementation
and the asymptotic properties of the resulting estimator are discussed in detail. Simulation
results and a real data analysis are provide to show satistifactory performance.
Section 5 is a summary of this dissertation, in which we discussed the advantages
and limitations of the proposed semiparametric approaches as well as the potential future
works worth exploration.
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2. SEMIPARAMETRIC EFFICIENT ESTIMATION IN GENE-ENVIRONMENT
INTERACTION MODEL UNDER INDEPENDENCE ASSUMPTION
2.1 Introduction
The etiology of most complex diseases, such as cancers and cardiovascular diseases,
is the joint effect of genetic susceptibility and environmental or non-genetic exposures, as
well as their interactions. Even subtle differences in genetic factors between people, when
exposed to the same environmental factors, can lead to dramatically different responses.
One common example is that sunlight exposure results in higher risk of developing skin
cancer among fair-skinned individuals than people with dark skin (Hunter, 2005; Ottman,
1996). Studying gene-environment interactions is thus of great importance to understand
disease mechanisms and develop new treatments and prevention strategies.
The case-control study design is commonly used to investigate the intricate interplay
of genetic susceptibility and environment effects. It is cost-efficient and convenient to
implement compared to a cohort study, especially when dealing with relatively rare dis-
eases (Chatterjee et al., 2009). Instead of taking a random sample from the underlying
source population, the case-control design randomly draws a fixed number of cases (dis-
eased subjects) and a comparable number of controls (non-diseased subjects) from the
respective case and control subpopulations. Genetic and environmental factors are then
measured and recorded for these sampled subjects in a retrospective fashion. The standard
approach for the analysis of such a case-control study is prospective logistic regression,
which ignores the underlying retrospective nature of the case-control design. Cornfield
(1956) showed the equivalence of prospective and retrospective odds ratios, which vali-
dates the prospective approach. Prentice and Pyke (1979) further showed that prospective
logistic regression analysis gives an efficient estimator, in the sense that it yields the maxi-
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mum likelihood estimates of the odds ratio parameters under a semiparametric model that
allows an arbitrary covariate distribution.
Despite of this, prospective logistic regression treatment in a case control study can
still require a large sample size to obtain adequate statistical power for detecting gene-
environment interactions or testing other hypotheses of interest. As a consequence, epi-
demiological researchers often exploit the potential efficiency gain from further assuming
certain parametric or semiparametric structures for the covariate distribution. For example,
in practice, a common assumption is that genetic susceptibility and environmental expo-
sure are independent in the underlying source population (Piegorsch et al., 1994), possibly
given strata. Under such a model, prospective logistic regression analysis is still valid but
may not be efficient because it ignores gene-environment independence.
A growing number of articles have been published in the last two decades, proposing
analytical methods that exploit gene-environment independence assumption (Chatterjee
and Carroll, 2005; Gauderman et al., 2013; Han et al., 2015; Ma, 2010; Murcray et al.,
2009; Piegorsch et al., 1994). Piegorsch et al. (1994) showed that under gene-environment
independence and a rare disease assumption, the multiplicative interaction odds-ratio pa-
rameter can be estimated by cases alone and the resulting estimator is more precise than
the estimator from traditional prospective logistic regression analysis using both cases and
controls. However, the misuse of a rare disease assumption in analyzing diseases with
moderate prevalence or diseases with small marginal probability in the source population
but high risk for certain combination of genetic and environmental exposures can lead to
considerable bias in the estimation. Noting this fact, Chatterjee and Carroll (2005) devel-
oped a semiparametric maximum likelihood estimator employing the gene-environment
independence assumption but not requiring any rare-disease assumption. Their approach
leaves the distribution of the environmental exposures totally unspecified but restricts ge-
netic susceptibility to have a discrete distribution that takes values in a finite and fixed
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set. Ma (2010) proposed a semiparametric efficient estimator in the same setting as Chat-
terjee and Carroll (2005) except the distribution of genetic susceptibility is allowed to be
either discrete or continuous with a finite-dimensional parameter. The key ingredient of
this approach is to construct a hypothetical population with infinite population size and
a disease to non-disease ratio of n1/n0, where n1 and n0 are the numbers of cases and
controls in the case-control sample. Section 2 of Ma (2010) showed that the case-control
sample can be viewed as a size n = n0+n1 random sample of independent and identically
distributed observations from this hypothetical population, and hence classical semipara-
metric analysis is applicable. The validity and usefulness of such a hypothetical population
was established in Ma (2010).
In this section, we consider a more general setting which keeps the gene-environment
independence assumption, while further allowing an unknown disease rate and completely
nonparametric distributions for both the genetic susceptibility and the environmental expo-
sure. Under such a model setting, we adopt the hypothetical population framework of Ma
(2010) and derive the semiparametric efficient estimator by employing a semiparametric
approach, which links the efficient estimator with the efficient score function. Through-
out our work, the underlying source population is referred to as the true population to
emphasize the difference between the underlying source population and the hypothetical
population. The inherent connection between the two populations allows us to transport
parameter estimation and inference results derived in the hypothetical population directly
to those in the true population, see Theorem 1. Although general semiparametric the-
ory applies in the hypothetical population framework, computing the efficient estimator
in this context is technically challenging because the efficient score does not have an ex-
plicit form and must be solved from an integral equation. We adopt a simple numerical
approach to solve the integral equation by discretizing the distribution of the genetic sus-
ceptibility when it is continuous. The resulting estimator, when properly implemented, is
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asymptotically linear with optimal efficiency.
The rest of the section is organized as follows. The specific model and the hypothetical
population framework are presented in Section 2.2, with the corresponding identifiability
conditions provided in Appendix A.1. In Section 2.3, we formulate the problem by using
a conventional semiparametric approach. The analytic expression of our semiparamet-
ric efficient estimator as well as its detailed implementation are discussed in this section.
Section 2.4 illustrates the asymptotic properties of the resulting estimator. Several simula-
tion studies are conducted in Section 2.5 to demonstrate the numerical performance of our
semiparametric efficient estimator compared with prospective logistic regression. A real
data analysis is provided in Section 2.6, followed with a brief discussion in Section 2.7.
Technical details and proofs are given in Appendix A.
2.2 Model And Framework
Let D denote the binary indicator of disease status, with D = 0 representing the
absence and D = 1 the presence of a disease. Let the genetic susceptibility be G and the
environmental exposuresX . Assume that the prospective risk given the covariates (G,X)
follows a logistic model
pr(D = d | G = g,X = x) = f trueD|G,X(d, g, x) = H(d, g, x,θ)
=
exp[d{α +m(g, x,β)}]
1 + exp{α +m(g, x,β)} , (2.1)
where θ = (βT, α)T and m(·) is a function known up to the parameter β. Here and
throughout the text, the superscript “true” is used to emphasize that those quantities are
related to the true source population. In addition, in the true population, G and X are
assumed to be independent so that the joint probability density/mass function of G,X can




X (x) = η1(g)η2(x). Here, for notational simplicity,
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we write {f trueG (g), f trueX (x)} as {η1(g), η2(x)}. The problem stated above is identifiable
in the case-control study under mild conditions, which are given in Appendix A.1, along
with the proof of identifiability.
The hypothetical population/tilted study joint density/mass function of (D,G,X) is





























η1(g)η2(x)H(d, g, x,θ)dµ(x)dµ(g). (2.3)
We consider η(·) = {η1(·), η2(·)} as the infinite-dimensional nuisance parameter. The
approach of Ma (2010) views this as a semiparametric problem, to be solved using tech-
niques explained in Bickel et al. (1993) and Tsiatis (2007). Here, the concept of hypo-
thetical population and the corresponding tilted likelihood is used as a vehicle to allow
us to transport the semiparametric tools for direct application. It enables us to construct
consistent estimators without having to concern about the non-random sample issue in
case-control study. Because the non-random sampling issue is already taken into account
when we formulate the tilted likelihood, the resulting estimator is indeed automatically
consistent under the original case-control sampling framework, that is, if the case-control
sample size grows to infinity while retaining the relative sample proportion of n1/n0, the
estimator will converge to the true parameter value. We formally write out this result in
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Theorem 1.
Theorem 1. Assume (di, gi, xi), i = 1, . . . , n, is a case-control sample with n1 cases, n0
controls, and with disease model (2.1) and independence of X and G. Assume d˜i, g˜i, x˜i,
i = 1, . . . , n, is a random sample of iid observations with size n from model (2.2). Then,
if θ̂{(d˜1, g˜1, x˜1), . . . , (d˜n, g˜n, x˜n)} is a root-n consistent regular asymptotically linear es-
timator of θ and satisfies E[θ̂{(d˜1, g˜1, x˜1), . . . , (d˜n, g˜n, x˜n)} | D] − θ = op(n−1/2), then
so is θ̂{(d1, g1, x1), . . . , (d1, g1, x1)}.
Theorem 1 essentially says that if we can develop a root-n consistent estimator based
on a random sample from model (2.2), then we can simply apply this estimation procedure
to the case-control sample and we will still get a root-n consistent estimator. The proof of
the Theorem 1 is the entire content of Section 2 of Ma (2010).
We take advantage of this property to generate an estimation procedure, which we
will then show consistently estimates the parameters when using the case-control data.
In particular, the procedure is not dependent on the hypothetical population/tilted study
formalism.
2.3 Analytic Derivations: Efficient Score and Algorithm
The outline of the semiparametric approach is to first construct a Hilbert spaceH, con-
sisting of all measurable functions with mean zero and finite variance. We next decompose
H into nuisance tangent space Λ and its orthogonal complement Λ⊥. The efficient esti-
mator can then be obtained by solving 0 =
∑N
i=1Seff(Di, Gi, Xi;θ), where Seff is the
projection of the score function Sθ onto Λ
⊥, and thus Seff is called efficient score function.
Careful calculation shows that the score function under the hypothetical population
(2.2) takes the form
Sθ(d, g, x) = S(d, g, x)− E(S | d),
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where S = {d − H(1, g, x,θ)}{m′β(g, x,β)T, 1}T and m′β(g, x,θ) ≡ ∂m(g, x,θ)/∂β.
Let p denote the dimension of θ. The final form of the Λ and Λ⊥ are listed below with the
detailed derivation provided in Appendix A.2. Specifically,
Λ = [a1(G) + a2(X)− E{a1(G) + a2(X) | D} : for all a1(G), a2(X)] ,
Λ⊥ = [f(D,G,X) : E(f | G) = E{E(f | D) | G},
E(f | X) = E{E(f | D) | X}, E(f) = 0].
Define Sx(x) = E(Sθ | x) = E(S | x) − E{E(S | D) | x} and Sg(g) = E(Sθ | g) =
E(S | g)− E{E(S | D) | g}. Projecting the score function onto Λ⊥ shows that
Seff(d, g, x) = S(d, g, x)− a(g)− b(x)− E{S(d,G,X) | d}+ E{a(G) + b(X) | d},
where
E{a(G) | x}+ b(x)− E{E(a+ b | D) | x} = Sx(x), (2.4)
a(g) + E{b(X) | g} − E{E(a+ b | D) | g} = Sg(g). (2.5)
It is easy to check that E{Seff(d,Gi, Xi) | d} = 0.
In order to obtain the efficient score function, we need to solve a and b from the
integral equations (2.4) and (2.5). The existence of the solution is automatically guaranteed
by the identifiability of the problem, whereas the uniqueness is not. However, it is shown
in Appendix A.3 that a and b are unique up to constant shifts. Thus, (2.4) and (2.5)
have a unique solution under the constraints E(a) = E(b) = 0. It is further proved
in Appendix A.4 that, under the mean zero constraint, (2.4) and (2.5) have an equivalent
expression, which is given by equations (A.1), (A.2), and (A.3) in Appendix. Such an
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equivalent expression allows us to separate a and b by introducing an intermediate variable
u0 = E(a + b | D = 0). However, there is no explicit expression for a and b. We still
need to solve the integral equation (A.1). In Appendix A.5, we propose an approximation
to its solution in the spirit of Tsiatis and Ma (2004), by discretizing X if X is continuous.
The detailed algorithm for constructing the efficient score function and computing the
efficient estimator for θ is given in Algorithm 1 below.
2.4 Distribution Theory
It is not surprising that the semiparametric estimator described in Algorithm 1 is
asymptotically normal with a parametric convergence rate and optimal efficiency as it is
formed by estimating all conditional expectations in the efficient score nonparametrically.
The asymptotic properties of our estimator are described in Theorem 2 under regularity
conditions C1-C2 listed below. The proof is provided in Appendix A.6.
C1 The univariate kernel function K(·) has support (−1, 1) and satisfies ∫ K(u)udu =
0,
∫
K(u)u2du <∞. The bandwidth h satisfies nh2 →∞ and nh8 → 0.
C2 Any discrete covariate has finitely many levels. Any continuous covariate has com-
pact support and its density function is twice continuously differentiable.
Theorem 2. Under the regularity conditions C1 and C2, the estimator θ̂ obtained from
solving the estimating equation 0 =
∑N
i=1Ŝeff(Di, Gi, Xi, θ̂) is asymptotically normal
with optimal efficiency, i.e.,
√
n(θ̂−θ)→ Normal{0, var(Seff)−1}, and is semiparametric
efficient.
2.5 Simulation Study
We performed simulations to understand the finite sample performance of the semi-
parametric efficient estimator described in Section 2.3 and demonstrate its superiority to
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Algorithm 1: Computing the Efficient Estimator
1. Estimate fX|D=d(·), the conditional density/mass function ofX given disease status
D = d, by nonparametric estimation among the data with Di = d for d = 0, 1.
Denote the result by f̂X|D(·).
2. Estimate fG|D=d(·), the conditional density/mass function ofG given disease status
D = d, by nonparametric estimation among the data with Di = d for d = 0, 1.
Denote the result by f̂G|D(·).
3. Define η̂1(g, π0) = π0f̂G|D=0(g) + (1− π0)f̂G|D=1(g), η̂2(x, π0) = π0f̂X|D=0(x) +
(1 − π0)f̂X|D=1(x), what we call a weighted nonparametric density/mass function
estimate, being weighted by the (estimated) population probabilities.
4. When (π0, π1) is unknown, estimate them by solving the integral equation
π0 =
∫
H(0, g, x)η̂1(g, π0)η̂2(x, π0)dµ(g)dµ(x),
and setting π̂1 = 1− π̂0, η̂1(g) = η̂1(g, π̂0), η̂2(x) = η̂2(x, π̂0).
5. Follow the method described in Appendix A.5 to obtain the solution of the integral
equations (2.4) and (2.5), with result â, b̂, and approximate E(â + b̂ | D) using
nonparametric density estimates f̂X|D(·) and f̂G|D(·), with result Ê(â+ b̂ | D).
6. Form Ŝeff(Di, Gi, Xi,θ) = Ŝθ(Di, Gi, Xi)− â(Gi)− b̂(Xi) + Ê{â(Gi) + b̂(Xi) |
Di}, and estimate θ by solving the estimating equation
n∑
i=1
Ŝeff(Di, Gi, Xi,θ) = 0.
It is critical that we estimate E{â(Gi) + b̂(Xi) | Di} and E(S | Di) involved in Steps
5 and 6 using f̂X|D(·) and f̂G|D(·) described in Steps 1 and 2 of the above algorithm,
instead of simply taking a sample version of the expectations. This ensures that all the
conditional expectations are computed using the same kind of approximation and the
gene-environment independence assumption is fully employed.
14
prospective logistic regression method under the gene-environment independent model.
Two scenarios are considered: (a) pr(D = 1) = 0.045 and (b) pr(D = 1) = 0.10,
corresponding to cases with a relatively rare disease rate and a common disease rate,
respectively. In each scenario, we generated X from the standard normal distribution
Normal(0, 1) or the gamma distribution with mean 20 and variance 20 Gamma(20, 1),
while the distribution of G is one of the following: (i) Bernoulli with success probability
0.6, where for example G = 1 or G = 0 corresponds to the presence or absence of a ge-
netic mutation, and (ii) Normal(0, 1), which can be used to model gene expression levels or
continuous traits, such as height and skin color, that are controlled by several genes. Given
G and X , we generated disease status D from the logistic regression model logit{pr(D =
1 | G,X)} = α + β1G + β2X + β3GX , where β = (β1, β2, β3)T = (0.76, 0.36,−0.63)
for both settings with normal X , and β = (β1, β2, β3)
T = (3.577, 0.080,−0.141) for
both settings with gamma X . We varied the intercept β0 in different simulations to get
the desired disease rate. Specifically speaking, in the case of X = Normal(0, 1), we set
α = −3.61 and −3.465 for binary G and normal G respectively to achieve a disease rate
of 4.5%, and we set α = −2.74 and -2.538 for binary G and normal G respectively to
achieve a disease rate of 10%. In the case ofX = Gamma(20, 1), we set α = −5.220 and
−5.086 for binary G and normal G respectively to achieve a disease rate of 4.5%, and we
set α = −4.352 and −4.158 for binary G and normal G respectively to achieve a disease
rate of 10%. For each setting, we simulated 1,000 data sets, each with n1 = 1, 000 cases
and n0 = 1, 000 controls. In the computation of the weighted nonparametric density/mass
function estimates defined in Algorithm 1, we used the asymptotically justified bandwidth
h = cn−1/5, where c ∈ [0.4, 1.2], and the results were insensitive to the choice of c.
The results are summarized in Tables 2.1-2.4. For 4.5% disease prevalence and nor-
mally distributed X (Table 2.1), it is clear that prospective logistic regression and our
semiparametric efficient estimator are both consistent, while the semiparametric estima-
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tor has smaller variance. Specifically, the semiparametric efficient estimator has a mean
squared error efficiency gain as large as 57% (the interaction term between G and X) for
binary G, and 46% (the interaction term between G and X) for the normal G. For 4.5%
disease prevalence and gamma X (Table 2.3), when G follows a Bernoulli distribution,
our semiparametric efficient estimator has a mean squared error efficiency gain between
31% (the main effect of X) and 56% (the interaction term between G and X); when G is
normal, the corresponding efficiency gain of the interaction term is 44%.
The results for the 10% disease rate case (Table 2.2 and 2.4) are similar. Both ap-
proaches are asymptotically valid, with our approach being superior to prospective logistic
regression in the sense that our semiparametric efficient estimator has better mean squared
error (MSE) results.
Binary G, Normal X Normal G, Normal X
β 0.76 0.36 -0.63 0.76 0.36 -0.63
Logistic
mean 0.761 0.363 -0.635 0.762 0.363 -0.634
se 0.101 0.088 0.103 0.055 0.053 0.056
est se 0.101 0.084 0.101 0.056 0.054 0.055
95% 0.952 0.939 0.942 0.950 0.954 0.942
Semi
mean 0.761 0.360 -0.630 0.761 0.362 -0.627
se 0.101 0.077 0.082 0.054 0.051 0.046
est se 0.100 0.073 0.079 0.053 0.051 0.041
95% 0.953 0.939 0.941 0.949 0.953 0.921
MSE Eff 1.003 1.325 1.566 1.068 1.112 1.457
Table 2.1: Simulation studies based upon 1,000 simulated case-control samples taken from
a population with a disease rate of approximately 4.5%, and independent genetic and envi-
ronmental variables, under the logistic model with gene-environment interaction. The re-
sults for binaryG ∼Bernoulli(0.6) andX ∼ Normal(0, 1) is displayed on the left whereas
the results for G ∼ Normal(0, 1) and X ∼ Normal(0, 1) is on the right. Each repli-
cate contains N1 = 1, 000 cases and N0 = 1, 000 controls, and is analyzed through two
approaches, (1) “Logistic” is ordinary logistic regression, and (2) “Semi” is our semipara-
metric efficient estimator. Here, we list the sample mean (“mean”), the sample standard
error (“se”), the mean estimated standard error (“est se”) and the coverage for the nominal
95% confidence intervals (“95%”) for both methods. In addition, we computed the mean
squared error efficiency of the “Semi” method compared to the “Logistic” approach.
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Binary G, Normal X Normal G, Normal X
β 0.76 0.36 -0.63 0.76 0.36 -0.63
Logistic
mean 0.762 0.365 -0.638 0.762 0.363 -0.633
se 0.102 0.084 0.100 0.056 0.051 0.057
est se 0.100 0.083 0.100 0.056 0.053 0.057
95% 0.943 0.952 0.955 0.957 0.960 0.952
Semi
mean 0.762 0.359 -0.628 0.761 0.363 -0.629
se 0.102 0.077 0.087 0.055 0.050 0.053
est se 0.100 0.074 0.081 0.055 0.052 0.050
95% 0.944 0.932 0.936 0.953 0.960 0.934
MSE Eff 1.004 1.180 1.325 1.032 1.065 1.145
Table 2.2: Simulation results from 1,000 simulated case-control samples taken from a
population with a disease rate of approximately 10%, and independent genetic and envi-
ronmental variables, under the logistic model with gene-environment interaction. The re-
sults for binaryG ∼Bernoulli(0.6) andX ∼ Normal(0, 1) is displayed on the left whereas
the results for G ∼ Normal(0, 1) and X ∼ Normal(0, 1) is on the right. Each repli-
cate contains N1 = 1, 000 cases and N0 = 1, 000 controls, and is analyzed through two
approaches, (1) “Logistic” is ordinary logistic regression, and (2) “Semi” is our semipara-
metric efficient estimator. Here, we list the sample mean (“mean”), the sample standard
error (“se”), the mean estimated standard error (“est se”) and the coverage for the nominal
95% confidence intervals (“95%”) for both methods. In addition, we computed the mean
squared error efficiency of the “Semi” method compared to the “Logistic” approach.
Binary G, Gamma X Normal G, Gamma X
β 3.577 0.080 -0.141 3.577 0.080 -0.141
Logistic
mean 3.599 0.081 -0.142 3.592 0.080 -0.141
se 0.456 0.018 0.022 0.269 0.012 0.012
est se 0.462 0.018 0.022 0.259 0.012 0.012
95% 0.957 0.953 0.949 0.937 0.950 0.942
Semi
mean 3.586 0.080 -0.141 3.569 0.080 -0.140
se 0.375 0.016 0.018 0.230 0.011 0.010
est se 0.369 0.016 0.017 0.202 0.011 0.009
95% 0.950 0.949 0.942 0.914 0.940 0.919
MSE Eff 1.484 1.305 1.559 1.372 1.059 1.437
Table 2.3: Simulation results from 1,000 simulated case-control samples taken from a
population with a disease rate of approximately 4.5%, and independent genetic G ∼
Bernoulli(0.6) and environmental X ∼ Gamma(20,1) variables, under the logistic model
with gene-environment interaction. Each replicate contains N1 = 1, 000 cases and
N0 = 1, 000 controls, and is analyzed through two approaches, (1) “Logistic” is ordinary
logistic regression, and (2) “Semi” is our semiparametric efficient estimator. Here, we list
the sample mean (“mean”), the sample standard error (“se”), the mean estimated standard
error (“est se”) and the coverage for the nominal 95% confidence intervals (“95%”) for
both methods. In addition, we computed the mean squared error efficiency of the “Semi”
method compared to the “Logistic” approach.
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Binary G, Gamma X Normal G, Gamma X
β 3.577 0.080 -0.141 3.577 0.080 -0.141
Logistic
mean 3.589 0.081 -0.141 3.600 0.081 -0.142
se 0.459 0.018 0.022 0.274 0.012 0.013
est se 0.460 0.018 0.022 0.269 0.012 0.012
95% 0.949 0.950 0.947 0.950 0.934 0.944
Semi
mean 3.565 0.080 -0.140 3.590 0.081 -0.142
se 0.394 0.016 0.019 0.268 0.012 0.012
est se 0.381 0.016 0.018 0.247 0.011 0.011
95% 0.945 0.953 0.938 0.934 0.937 0.930
MSE Eff 1.360 1.240 1.406 1.048 1.031 1.061
Table 2.4: Simulation results from 1,000 simulated case-control samples taken from
a population with a disease rate of approximately 10%, and independent genetic
G ∼Bernoulli(0.6) and environmental X ∼Gamma(20,1) variables, under the logistic
model with gene-environment interaction. Each replicate contains N1 = 1, 000 cases and
N0 = 1, 000 controls, and is analyzed through two approaches, (1) “Logistic” is ordinary
logistic regression, and (2) “Semi” is our semiparametric efficient estimator. Here, we list
the sample mean (“mean”), the sample standard error (“se”), the mean estimated standard
error (“est se”) and the coverage for the nominal 95% confidence intervals (“95%”) for
both methods. In addition, we computed the mean squared error efficiency of the “Semi”
method compared to the “Logistic” approach.
2.6 Example
Prostate cancer is a heterogeneous disease resulting from the complex interplay of
genetic susceptibility and environmental exposures. It is the second leading cause of can-
cer death among men in the US (Siegel and Jemal, 2015). Prostate cells (both primary
and cancer cells) were demonstrated to have 1α-OHase activity, whereas 1α-OHase is
the enzyme responsible for converting [25(OH)D], the major circulating form of vita-
min D that reflects both dietary and sunlight exposures, into 1,23-dihydroxy-vitamin D
[1,25(OH)2D], the most active form of this vitamin that can induce cell-cycle regulation,
apoptosis and differentiation in prostate cancer cells via the vitamin D receptor (VDR).
Thus, (a) [25(OH)D] is hypothesized to have an anticancer effect, and (b) an important
question is whether its relationship with the risk of developing prostate cancer is modified
by genetic polymorphisms in the VDR gene.
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In this section, we implemented our methodology in a case-control study of prostate
cancer, using the same data set analyzed differently but in a different context by Chen
et al. (2009), see that reference for details about the study. Specifically, our analysis is
based on a polygenic risk score, a single risk factor incorporating information from sus-
ceptibility SNPs, whereas Chen et al. (2009) focused on haplotypes. The data consist of
n1 = 690 cases and n0 = 717 controls randomly selected from the screening arm of a
large population-based cohort study, the Prostate, Lung, Colorectal, and Ovarian Cancer
Screening Trial (PLCO) at the National Cancer Institute. The PLCO cohort study recruited
a total of 76,685 men aged 55 to 74 at 10 screening centers between November 1993 and
July 2001, then randomly assigned 38,340 of them to the screening arm and the rest to the
non-screening arm. In a 10 year follow-up period, in the study population, the cumulative
incidence rate for prostate cancer in the screening arm was 108.4 per 10,000 person-years
(Andriole et al., 2012). Apart from case-control status, [25(OH)D] level (nmol/L) and
genotype data on 19 single-nucleotide polymorphisms (SNPS) are available for each sub-
ject involved in the case-control study. According to Chen et al. (2009), these polymor-
phisms, ourG, are unlikely to affect the [25(OH)D] level, ourX , as the VDR gene plays a
“downstream” role in the vitamin-D pathway. In other words, the gene-environment inde-
pendence assumption is likely to be valid in this application. Detailed information about
the design can be found in Andriole et al. (2012), Hayes et al. (2000), and Prorok et al.
(2000).
One difficulty in investigating the genetic modification of the VDR gene to [25(OH)D]
on the risk of prostate cancer is that the VDR gene contains multiple underlying suscep-
tibility SNPs, where each individual SNP may only confer a small component of overall
risk. In fact, running a logistic regression of case-control status on each of the 19 SNPs
shows only three SNPs have p-values ≤ 0.10. Recently, it has been recognized that the
polygenic risk score has the potential of improving risk prediction for some common dis-
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eases (Aly et al., 2011; Chatterjee et al., 2016; Dudbridge, 2013; Evans et al., 2009; Fuchs-
berger et al., 2016; Purcell et al., 2009). Therefore, we created a polygenic risk score for
the prostate cancer data by weighting those 19 SNPs, where the weights are the effect sizes
of separate logistic regressions applied to each SNP.
The results of prospective logistic regression and our semiparametric approach based
on 1,000 bootstrap samples are given in Table 2.5. The two sets of estimates are fairly
consistent as expected. However, our semiparametric efficient estimator has smaller stan-
dard errors than does the prospective logistic regression, in accordance with theory and our
simulations. This leads to a substantial difference in inference for the interaction between
the polygenic risk score and the [25(OH)D] level. Specifically, both prospective logis-
tic regression and our semiparametric efficient method show that the main effects of both
the polygenic risk score and the [25(OH)D] level is statistically significant and positive.
That is, if ignoring the interaction, men with higher polygenic risk scores or/and higher
[25(OH)D] levels tend to have higher risk of developing prostate cancer.
βG βX βGX
Logistic
Estimates 0.169 0.123 -0.101
se, bootstrap 0.056 0.056 0.054
est se, asymptotic 0.055 0.055 0.055
p-value, bootstrap 0.002 0.028 0.064
p-value, asymptotic 0.002 0.024 0.066
Semi
Estimates 0.168 0.124 -0.110
se, bootstrap 0.056 0.056 0.049
est se, asymptotic 0.055 0.054 0.042
p-value, bootstrap 0.003 0.027 0.026
p-value, asymptotic 0.002 0.021 0.009
Table 2.5: Analysis of the case-control study on prostate cancer, containing n1 = 690 cases
and n0 = 717 controls. Two approaches were implemented, (1) “Logistic” is ordinary
logistic regression, and (2) “Semi” is our semiparametric efficient estimator. Displayed
are the estimates, bootstrap standard error (“se, bootstrap”), mean estimated asymptotic
standard error (“est se, asymptotic”), bootstrap p-value (“p-value, bootstrap”), and asymp-
totic p-value (“p-value, asymptotic”) of the coefficients for the standardized polygenic risk
score (G), [25(OH)D] level (X), and the interaction between them (GX).
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Importantly, the estimates of the interaction parameter from the prospective logistic
regression is not significant at the 5% level. However, our approach shows significant
evidence of interaction, i.e., the effects of [25(OH)D] level on prostate cancer risk differ
depending on the polygenic risk score.
In addition, our approach provides an estimated disease rate in the population of
10.6%, whereas the disease rate in the PLCO cohort study is 10.8% per person-year. This
validation of our methodology suggests an additional use to which it can be applied.
2.7 Discussion
We have developed a semiparametric efficient estimator in case-control studies for the
gene-environment independent model, where the distributions of genetic susceptibility and
environmental exposure are allowed to be arbitrary and the disease rate is assumed com-
pletely unknown. We showed that despite of these weak assumptions, the problem is iden-
tifiable in most cases. The proposed estimator is derived under the so called hypothetical
population framework, which enables us to view the case-control sample as a random sam-
ple from a hypothetical distribution and thus facilitates the application of a conventional
semiparametric approach. Such an estimator is semiparametric efficient and its superior-
ity over the prospective logistic regression was demonstrated in various simulations. The
general methodology of our approach can be extended to parametric models other than the
logistic model, such as the probit model, and it can be used to consider assumptions other
than gene-environment independence, such as Hardy-Weinberg equilibrium, as long as the
resulting model is identifiable.
To handle the nuisance parameters in the estimation procedure, nonparametric den-
sity/mass function estimation are used. When the dimensions of genetic susceptibility or
environmental exposures increase, such nonparametric estimation suffers from the curse of
dimensionality. In such cases, dimension reduction techniques might be needed to main-
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tain model flexibility as well as ensure computation feasibility. This will be pursued in
future work.
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3. DIMENSION REDUCTION AND ESTIMATION IN THE SECONDARY
ANALYSIS OF CASE-CONTROL STUDIES
3.1 Introduction
The analysis on gene-environment independence model discussed in Section 3 is a
special case of primary analysis, where the covariates can be separated into independent
genetic and environmental (non-genetic) variables. Generally, covariates in primary anal-
ysis can be arbitrary risk factors potentially associated with the disease of interest and
the relationship between covariates is not necessary to be independence. For example, in
Section 3.6, we describe a case-control study involving breast cancer and its well known
risk factors including mammographic density and age at first live birth. We discover a
statistically significant effect of age at first live birth on mammographic density. Particu-
lary, women with a relatively late age at first live birth often have a lower mammographic
density.
The study that examine the interrelationship between covariates is known as secondary
analysis. Its main difficulty lies in the fact that the case-control data is not a random
sample from the underlying source population. In fact the case-control samples are taken
separately from the case subpopulation and the control subpopulation. As a consequence,
the relationship between covariates Y and X in the secondary analysis under the case-
control context can be very different from the relationship in the true population. Hence,
simply regressing Y on X and ignoring the case-control sampling scheme can be grossly
misleading.
A simple approach to secondary analysis is using only controls if the disease rate is
rare, say less than 1%. This type of approach is widely used, because if the disease rate is
< 1%, the controls make up more than 99% of the population, and analysis of them is close
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to that of the entire population. However, this approach can have relatively low efficiency
because it ignores the information carried by the cases. A more efficient approach is to
adopt a semiparametric framework, assuming a parametric distribution for Y given X,
e.g., linear regression with normally distributed and homoscedastic regression errors, as
well as known or rare disease rate (Jiang et al., 2006; Li et al., 2010; Lin and Zeng, 2009;
Tchetgen, 2014; Wei et al., 2013). This approach improves estimation efficiency compared
with the controls only method because both cases and controls are taken into account.
However, the disease rate in the source population being sampled is often unknown
and some diseases may not be so rare as less than 1%, so that the controls-only analysis
can have considerable bias. This prompted Ma and Carroll (2016) to propose a further
improved approach, which does not require a known or a rare disease assumption, and
also, unlike the papers referenced above, does not assume normality or homoscedasticity
of the regression error. In fact, they only specify a mean model to describe the relationship
between covariates. Their semiparametric estimator involves positing density functions for
X and Y givenX that may or may not be true. The resulting estimator is (a) consistent and
asymptotically normally distributed even if the posited functions are incorrectly specified;
and (b) it is efficient if the posited functions are correctly specified. An estimator with the
properties (a) and (b) will be called locally efficient throughout this article.
Because the approach of Ma and Carroll (2016) was developed by adopting a hypothet-
ical population concept and viewing case-control samples as independent and identically
distributed observations sampled from the hypothetical population, they need to link the
quantities in the hypothetical population to the ones in the true population. As a con-
sequence, several additional conditional distributions arise in the likelihood formulation,
including quantities conditional on the covariates. This leads to the need to perform sev-
eral nonparametric regressions on the covariates in their estimator. When the covariate
dimension increases, such nonparametric regressions inevitably suffer from the curse of
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dimensionality.
In this section, we work in the hypothetical population framework and handle the po-
tential dimensionality problem using a dimension reduction modeling approach. We as-
sume several quantities of interest depend on the covariates X only through linear com-
binations of X and/or known functions of X. This allows us to avoid multivariate non-
parametric regression. However, because of the inherent relation between the covariates
assumed in the original true population, the dimension reduction structure is not com-
pletely arbitrary. Instead, it is subject to various constraints, which makes the problem
different from the classical dimension reduction modeling and estimation. Taking these
various special features into consideration, we construct asymptotically consistent estima-
tors for the regression parameters in the true population model. These estimators have
a parametric convergence rate and are robust to the misspecification of the conditional
distribution of Y givenX.
The rest of the section is organized as follows. In Section 3.2, we introduce the model
and notation we use. We propose a locally efficient estimator using the single index model
in Section 3.3. We derive the asymptotic properties of the resulting estimators in Section
3.4. In Section 3.5, we report simulation results, compare our method with the control only
method and the semiparametric efficient method that assumes normality and homoscedas-
ticity on the error (Lin and Zeng, 2009). We analyze a mammographic density data set with
our approach in Section 3.6, and follow with a brief conclusion in Section 3.7. Technical
details and proofs are provided in an Appendix.
3.2 Methodology
3.2.1 Background
Let D be disease status, where D = 1 denotes a case and D = 0 denotes a control.
Also let (XT, Y )T be a (p+1)×1 vector of covariates, whereX is a p-dimensional vector
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and Y is a scalar. We assume that both X and Y are continuous and they are related to
disease status D via a logistic regression model
pr(D = d|X = x, Y = y) = f trueD|X,Y (d,x, y) = H(d,x, y,α)
=
exp{d(αc + xTα1 + yα2)}
1 + exp(αc + xTα1 + yα2)
, (3.1)




As mentioned before, the goal of secondary analysis is to investigate the relationship
betweenX and Y in the source population, which we assume is of the form
Y = m(X,β) + ǫ, (3.2)
where m(·) is a smooth function known up to a parameter β. The error term ǫ satis-
fies Etrue(ǫ|X) = 0, but no other assumptions about ǫ are made, especially normality
or homoscedasticity or independence from X. Under mild conditions, the parameters
θ = (αT,βT)T defined in (3.1) and (3.2) are identifiable (Ma and Carroll, 2016).
3.2.2 Hypothetical Population Model Framework and Efficient Estimator
From model (3.2), the conditional distribution of Y givenX and the marginal distribu-
tion ofX with respect to the true population are
f trueY |X(y,x,β) = η2{y −m(x,β),x} = f trueǫ|X (ǫ,x), (3.3)
f true
X
(x) = η1(x). (3.4)
Here η2 is an unknown probability density function with mean 0, which is free of the un-
known parameters β, ǫ is the error term defined in (3.2), i.e., ǫ = Y −m(X,β) and η1 is
another probability density function which is also unknown. The superscript “true” em-
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phasizes that the probability densities in (3.3) - (3.4) are defined under the true population.
Suppose we draw a case-control sample withN1 cases andN0 controls. Because of the
sampling design, classical large-sample asymptotic theory does not work here. The idea
of a hypothetical population is to construct a hypothetical population with infinite sample
size and a fixed ratio of cases to controls, N1/N0, then treat the case-control sample as
a random sample from the hypothetical population with sample size N = N0 + N1 (Ma,
2010). The explicit form of the joint density of (X, Y,D) in such a hypothetical population
is
fX,Y,D(x, y, d) = (Nd/N)f
true







Here we use the fact that the distribution of (X, Y ) conditional on the disease status D
in the hypothetical population and in the true population are identical, which links the
distributions in these two populations.
Ma and Carroll (2016) derived the semiparametric efficient score function correspond-
ing to the above hypothetical population, Seff(Xi, Yi, Di) = {S(Xi, Yi, Di) − g{Yi −
m(Xi,β),Xi)} − (1−Di)v0 −Div1. The resulting efficient estimating equation is
∑N
i=1{S(Xi, Yi, Di)− g{Yi −m(Xi,β),Xi)} − (1−Di)v0 −Div1 = 0, (3.5)
where
S(x, y, d,θ) =
 ∂log{H(d,x, y,α)}/∂α∂log{η2(ǫ,x)}/∂β
 . (3.6)
Although as a function, η2 does not depend on β, its first argument ǫ contains β. Other
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quantities used in (3.5) are defined in (3.7).
π0 ≡ ptrueD (0) =
∫
η1(x)η2(ǫ,x)H(0,x, y)dµ(x)dµ(y);
π1 ≡ ptrueD (1) =
∫
η1(x)η2(ǫ,x)H(1,x, y)dµ(x)dµ(y);
b0 ≡ E{fD|X,Y (1,X, y) | D = 0}; b1 ≡ E{fD|X,Y (0,X, y) | D = 1};
µs(x, y) ≡ E(S | ǫ,X = x); c0 ≡ E(S | D = 0) − E{µs(X, Y ) | D = 0};
c1 ≡ E(S | D = 1)− E{µs(X, Y ) | D = 1};
κ(x, y) ≡ [∑1d=0{NdH(d,x, y)}/(Nπd)]−1;
t1(X) ≡ [Etrue {ǫ2κ(X, Y ) | X}]−1;
t2(X) ≡ Etrue {ǫµs(X, Y ) | X} − (c0/b0)Etrue
{
ǫfD|X,Y (0,X, Y ) | X
}
;
t3(X) ≡ −b−10 Etrue
{
ǫfD|X,Y (0,X, Y ) | X
}
; a(x) ≡ t1(x){t2(x) + t3(x)u0};
u0 ≡ (1− E [ǫt1(X)t3(X)κ(X, Y ) | D = 0])−1E [ǫt1(X)t2(X)κ(X, Y ) | D = 0];
u1 ≡ −(N0/N1)u0;v0 ≡ (π1/b0)(u0 + c0);v1 ≡ −(π0/b0)(u0 + c0);
g(ǫ,x) ≡ µs(x, y)− ǫa(x)κ(x, y)− v0fD|X,Y (0,x, y)− v1fD|X,Y (1,x, y).
(3.7)
3.3 Approach via Dimension Reduction
3.3.1 Background
The estimating equation (3.5) contains three expectations conditional on covariates
X, i.e.,Etrue {ǫ2κ(X, Y ) | X} , Etrue {ǫµs(X, Y ) | X} andEtrue
{
ǫfD|X,Y (0,X, Y ) | X
}
,
which need to be estimated nonparametrically. However, such estimation may be ex-
tremely hard when the covariates X are multivariate. To bypass the potential curse of
dimensionality problem caused by the multivariate nature ofX, we use a dimension reduc-
tion modeling strategy, i.e., we assume all three quantities in the conditional expectations
depend on X only through several linear combinations XTγ or several linear combina-
tions of functions of X. Under such a dimension reduction structure, we can construct
nonparametric regression estimators for high dimensional covariates X in a way similar
to the univariate case with desired bias and MSE order, hence facilitating the estimation
procedure via solving the estimating equation (3.5).
Let f0(X, Y,α) = fD|X,Y (0,X, Y ). All three functions κ(x, y),µs(x, y) and f0(x, y)
28
depend on πd = πd(α). To emphasize this, we replace πd with πd(α˜) in those three
functions and we use the notation κ(x, y, α˜),µs(x, y, α˜), f0(x, y, α˜) to distinguish them
from the ones using the true parameter value α. In addition, we define ǫ(X, Y, β˜) =
Y −m(X, β˜) to distinguish it from the true ǫ = Y −m(X,β).
There are two cases that need to be considered, namely that (i)m(·) defined in (3.2) is
a linear function of X; and (ii) that m(·) is not a linear function of X. In case (i), we set
Z
β˜
= X, while in case (ii), we set Z
β˜
= {XT,m(X, β˜)}T.
Then our dimension reduction models are
Etrue{ǫ2(X, Y, β˜)κ(X, Y, α˜) | X} = ζ1(ZTβ˜γ1, α˜), (3.8)
Etrue{ǫ(X, Y, β˜)µs(X, Y, α˜) | X} = ζ2(ZTβ˜γ2,X, α˜), (3.9)
Etrue{ǫ(X, Y, β˜)f0(X, Y, α˜) | X} = ζ3(ZTβ˜γ3, α˜), (3.10)
for α˜ and β˜ that are in a neighborhood ofα and β. Here Z
β˜
is a finite dimensional vector,
each element of which is a function of X. The subscript β˜ indicates Z
β˜
may depend on
the unknown parameter β˜. The three indices γ1,γ2,γ3 are vectors or matrices that have
the same row size as the length of Z
β˜
and with ℓ columns. The lower square blocks of
all three matrices γ1,γ2,γ3 are set to be identity to ensure identifiability. Throughout the
text, we use the notation γ−1 to denote the submatrix of γ without the lower square block
for any matrix γ. ζ1(·), ζ2(·), ζ3(·) are three unknown functions. Strictly speaking, model
(3.9) is not a standard dimension reduction model. However, in Appendix B.1, we describe
its actual form, which in general consists of three different standard dimension reduction
models.
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3.3.2 Data Generating Mechanisms for Which (3.8)-(3.10) are Valid
The dimension reduction models (3.8)-(3.10) are used here only as working models to
facilitate the estimation procedure. We do not intend to include these models as part of
our original model assumptions and thereby take these structures into account to further
improve estimation efficiency.
There are at least two simple and important data generating mechanisms for which
(3.8)-(3.10) hold: (a) when ǫ is independent of X; and (b) when, as in equation (1) of
Lian et al. (2015), ǫ = v(XTω)ǫ∗, where v(·) is an unknown smooth function and ǫ∗ is
independent of X with mean 0 and variance 1. More generally, we have the following
result, proved in Appendix B.4, and including the two special cases given above..
Proposition 1. Suppose ǫ = Q(XTω, ǫ∗), where Q(·) is an arbitrary smooth function and
ǫ∗ is independent ofX. Then the dimension reduction models (3.8)-(3.10) hold.
3.3.3 Estimation
As stated in Section 3.3.2, models (3.8)-(3.10) can often be used as working models to
facilitate the multivariate nonparametric regression. Therefore, in the rest of the derivation,
we use the general model (3.8)-(3.10) without specifying the particular form of Z
β˜
. Of
course, we need to estimate γj and ζj(·) for j = 1, 2, 3. To resolve the issue of estimating
conditional expectations in the true population while we only have a random sample from
the hypothetical population, the key point is to recognize the connection between the two
populations and to adjust the case-control data in the context of conditional expectations
via
Etrue{h(D,X, Y )} =
∑1
d=0πdE{h(D,X, Y ) | D = d},
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where h(·) is any function such that h(D,X, Y ) has finite mean. Hence we can simply
weight cases by π1/N1 and controls by π0/N0 and this will give us the ζj(·)’s. Take ζ1(·)











i=1I(Di = d){ǫ2iκ(Xi, Yi)− ζ1(zTγ1)}Kh(zTγ1 − ZTi γ1)]
=
∑1
d=0πdEtrue[{ǫ2κ(X, Y )− ζ1(zTγ1)}Kh(zTγ1 − ZTγ1)|D = d]




ℓ for u = (u1, · · · , uℓ)T for any ℓ-dimensional vector u.
Of course πd is not known. Thus, to implement the idea stated in (3.11), we need an




(N0/N)H(0,X, Y,α) + (N1/N)H(1,X, Y,α){π/(1− π)}
]
= 1 (3.12)
has a solution π = π0(α). It is the unique solution as long as pr{H(0,X, Y,α) > 0} > 0,
since π/(1− π) is strictly increasing, ranging from 0 to∞. Based on (3.12), we can con-
struct a root-N consistent estimator of π0 and plug it into (3.11). The resulting estimators
of the ζ1(·) have the same bias and mean squared error order as the usual nonparametric
estimator. The proof is provided in Supplementary Material B.5.
For simplicity, one may use the same index in (3.8)-(3.10), i.e. assuming γ1 = γ2 =
γ3 = γ. As before, we restrict the lower square block of γ to be identity. We provide de-
tailed estimation procedures and algorithms for both cases, with the algorithm for different
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indices in Appendix B.2.1 and that for the same index in Appendix B.2.2.
Remark 1. It is worth pointing out that the estimation of π via (3.12) originates from
π0 =
∫














Thus, the estimator takes into account the difference between the hypothetical popula-
tion and the population from which the case-control sample is drawn, and thus leads to a
consistent estimator of π0.
3.3.4 Estimation Algorithm Using Different Indices
The estimating equation in (3.5) relies on the unknown probability density function
η2. Here, we use a posited model η
∗
2 , which is not necessarily the truth, to calculate the
efficient score and other related quantities. The resulting estimating function is denoted
by S∗eff . We will show that the resulting estimator is still consistent, and it is efficient if the
posited model η∗2 is the correct one.
The main difficulty in calculating S∗eff lies in approximating functions g,v0,v1, be-
cause they depend on three expectations conditional on covariates X, which need to be
estimated nonparametrically. We bypass this difficulty via the dimension reduction strat-
egy described in Section 3.3.1-3.3.3. A sketch of the algorithm is the following.
1. Posit a model for η2(ǫ,x) which has mean zero. Under this posited model, calculate
S∗ from (3.6).
2. Solve π̂0(α) =
∑N
i=1H(0,Xi, Yi,α)[N0H(0,Xi, Yi,α)/π̂0(α) +N1H(1,Xi, Yi,
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α)/{1− π̂0(α)}]−1, and set π̂1(α) = 1− π̂0(α).
3. Estimate the indices γ1,γ2,γ3 and the corresponding functions ζ1, ζ2, ζ3 defined in
(3.8)-(3.10) respectively by following the procedure in Section 3.3.3.
4. Plug the estimation from Step 3 into the expression of functions g,v0 and v1 in (3.7)
to get ĝ, v̂0 and v̂1.
5. Form Ŝ∗eff(Di,Xi, Yi) = S
∗
i − ĝi − v̂Di and solve the corresponding estimating
equation.
For convenience, we adopt γ1 = γ2 = γ3 = γ in all the simulations, where the lower
square block of γ is set to be identity to ensure identifiability. The algorithm in this sim-
plified case is identical to the one described above except step 3. The detailed algorithms
for cases using different indices and using a common index are given in Appendix B.2.
3.4 Distribution Theory
We now establish the asymptotic distribution theory of our estimators, stated as The-
orem 3 below, with necessary regularity conditions C1-C11 listed in Appendix B.3. The
proof of Theorem 3 is detailed and lengthy and is thus sketched in the Supplementary
Material Section B.5. While Theorem 3 holds for both the estimator using different in-
dices and the estimator using a common index, we only provide the proof and regularity
conditions for the algorithm with different indices. One can easily adapt the conditions
and proof to the case of a common index.
Under the regularity conditions C1-C11 listed in Appendix B.3, the following theorem
holds. The proof is in the Supplementary Material Section B.5.
Theorem 3. DefineA = E {∂S∗eff(D,X, Y,θ)/∂θ} andB = cov {S∗eff(D,X, Y,θ)}. The
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estimator θ̂ obtained from solving the estimating equation
N∑
i=1
Ŝ∗eff(Di,Xi, Yi, θ̂) = 0 (3.13)
satisfies
√
N(θ̂ − θ)→ Normal{0,A−1B(A−1)T} and θ̂ is locally efficient, see the defi-
nition of locally efficient in Section 3.3.1.
3.5 Simulations
3.5.1 Setup
We performed a series of simulations to understand the behaviour of our method and
compare it to competitors. The simulations displayed in this section are for the case that
the regression errors ǫ are Gaussian or centered Gamma, both homoscedastic and het-
eroscedastic.
In these simulations, we considered different disease rates, different dimensions and
distributions for X and different error variance structures. The results indicate that our
methods have small bias and good coverage probability in all the cases we examined.
Here, due to space limitations, we only list the results for two typical scenarios, where the
first one is homoscedastic and the second one is heteroscedastic. In both cases, we chose
a balanced design with N1 = 1000 cases and N0 = 1000 controls, set the disease rate to
be approximately 4.5% and letX be exchangeable with p = dim(X) = 4.
More specifically, we generatedX = (X1, · · · , X4)T in the following way.
1. Generate X∗ = Normal(0,Σ), where Σ = (Σi,j)1≤i,j≤4 and Σi,j = 1 if i = j and
Σi,j = ρ for |ρ| < 1 if 1 ≤ i 6= j ≤ 4.
2. Let X = Φ(X∗) = {Φ(X∗1), · · · ,Φ(X∗4)}T, where Φ is the cumulative distribution
function of a standard normal random variable.
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Hence, X is an exchangeable vector of random variables satisfying Xi = Uniform[0, 1]
for i = 1, · · · , 4 and corr(Xi, Xj) = corr(Xk, Xl) for all i 6= j, k 6= l. In our simulation
studies, we used ρ = 0.2, which resulted in corr(Xi, Xj) ≈ 0.191 for all 1 ≤ i 6= j ≤ 4.
As mentioned in the opening paragraph of this section, in this section we display
results when the regression errors are Gaussian or Gamma. Specifically, we generated
homoscedastic errors ǫ as Normal(0, 1) and we generated heteroscedastic errors ǫ such
that [ǫ | X] = Normal (0, [1 + {XT(α1 + α2β1)}2]3/2/4). In the Gamma case, we
generated homoscedastic errors ǫ from a Gamma distribution with shape parameter 0.4,
scale parameter 1.8 and then normalized it to have mean 0 and variance 1; we gener-
ated heteroscedastic errors ǫ using the same distribution except that ǫ was multiplied by
[1 + {XT(α1 + α2β1)}2]3/4/2.
To obtain an approximately 4.5% disease rate in both Gaussian and Gamma cases with
both homoscedastic and heteroscedastic errors, we first set αc = −3.6,α1 = (−1.0, 0.3,
0.5, 0.7)T and α2 = 0.6 in the logistic model pr(D = 1|X, Y ) = H(αc +XTα1 + Y α2).
Then we set the regression model for Y to be linear, i.e., Y = β0 + X
Tβ1 + ǫ and let
β0 = −1.1,β1 = (0.5, 1.0, 0.3, 0.5)T. For each setting, we generated 1,000 simulated data
sets.
We set the posited model η∗2 to be Normal(0, 1) and adopted the estimation algo-
rithm discussed in Section 3.3.4 and Appendix B.2 for the important conditional expec-
tations Etrue {ǫ2κ(X, Y ) | X}, Etrue {ǫµs(X, Y ) | X} and Etrue
{
ǫfD|X,Y (0,X, Y ) | X
}
.
In steps (1)-(3) in Appendix B.2 that involves nonparametric calculations, we used the
asymptotically justified bandwidth h = cn
−1/5
0 : we found that when c ∈ [1, 6], the estima-
tion results are very similar.
35
3.5.2 Results
We contrasted three methods. The first one is ordinary least squares using controls
only. The second one is the semiparametric efficient method that assumes the regression
error ǫ to be normally distributed with homoscedastic variance and E(Y | X) to be linear
in X, or equivalently in our notation, m(X,β) = β0 + X
Tβ1 (Lin and Zeng, 2009).
This method also requires a rare or known disease rate, which was set to 0.1% in the
simulations. The third is our method described in Section 3.3.4, which does not require the
rare disease assumption and does not put any restriction on ǫ other than that E(ǫ|X) = 0.
To implement Lin and Zeng’s method, we used their software SPREG provided on
http://dlin.web.unc.edu/software/spreg-2/, which adopts the rare disease assumption if the
input disease rate is less than 1%. This software was designed to work in a semiparametric
framework where it assumes a fully parametric Gaussian model for ǫ but the distribution
of X is nonparametric. However, through multiple attempts we found that their software
can only handle the case where components of X are independent. Thus, before running
SPREG, we decorrelated X by multiplying it by L−1, where L is the Cholesky decom-
position of the cov(X) = Σ satisfying LLT = Σ. In the simulations, we used the true
covariance matrix Σ to fulfill the restriction of SPREG. However when dealing with the
mammographic density data in Section 3.6, the true covariance matrix Σ is unknown. We
estimated it using only the controls.
The results are summarized in Tables 3.1-3.2. In the homoscedastic Gaussian scenario
(Table 3.1), the approach using only controls (“Control”) is asymptotically valid with small
bias and near nominal coverage. Lin and Zeng’s method (“Param”), which assumes nor-
mality and homoscedasticity, has the smallest standard deviation among the three methods
since it is efficient if the errors are normal. However, it suffers from slight bias since the
true disease rate is 4.5%, larger than 1%. Our method (“Semi”), which assumes neither
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normality nor rare disease, is superior considering overall performance. It has the smallest
bias compared with the other two methods. In addition, its mean-squared error efficiency
is from 60.0% to 79.9% greater than using only controls and is comparable to Lin and
Zeng’s method. In the homoscedastic Gamma case (Table 3.2), Lin and Zeng’s methods
has considerable bias, under-coverage and loss of mean squared error efficiency.
In the heteroscedastic scenario, for both Gaussian and Gamma errors, both the “Con-
trols” and the “Param” methods suffered from low coverage probabilities while our ap-
proach (“Semi”) maintains nominal coverage. The approach using only controls is rea-
sonably unbiased in the Gaussian case but suffers from much larger bias in the Gamma
case. In both cases, Lin and Zeng’s parametric method gives badly biased estimates, low
coverage probabilities and low mean squared error efficiency. Taking β13, the third ele-
ment in β1, as an example, while the nominal coverage is 95%, the actual coverage rates
are 40.6% and 43.7% in the Gaussian and Gamma case, respectively. Our approach has
no larger than 4% bias compared with the truth, which is the best among three methods. It
also achieves the best coverage probabilities and smallest mean-squared errors.
Remark 2. We have compared our approach to two methods, the control only method and
Lin and Zeng’s method. The control only method is simple and quick and can work sur-
prisingly well when the disease is truly rare. Lin and Zeng’s method is the gold standard in
practice. In fact, there are a number of other works on secondary analysis in the literature,
however none of them is applicable in our setting. For example, Jiang et al. (2006) and
Li et al. (2010) focused on binary Y , for which a logistic regression model between Y
and X (or Y and (X, D)) was considered. Ma and Carroll (2016) adopted kernel density
regression in their estimation procedure, and thus it is not applicable to the cases with mul-
tivariate X due to the curse of dimensionality. Wei et al. (2013) requires the rare disease
assumption as well as homoscedastic regression errors, and hence is not applicable in our
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model setting.
3.6 Analysis of Mammographic Density Data
Here we apply our methodology in a case-control study of breast cancer, where the
data were collected from women in the breast cancer detection demonstration project
(BCDDP), see Chen et al. (2006) and Chen et al. (2008). The study recruited a total
of 284,780 women, starting from January 1, 1973 and ended December 31, 1995. Then
in the following five years, follow-up annual screening was performed for each subject.
Here the period from 1973-1980 is referred to as the “screening phase” of the study. At
the end of the screening phase, the study selected all cases, i.e. women who developed
breast cancer, and sampled from the controls. All the selected women were included in
a further extended follow-up study from 1980 to 1995. Standard risk factors, including
age at menarche, age at first live birth and body mass index, were available in this study.
However, we were only able to retrieve mammographic density measurements at baseline
in 1973-1975 for N1 = 2092 cases and N0 = 3295 controls.
Mammographic density is a measure of the average of dense tissue percentage in both
breasts. Women’s breasts consist of fat, breast tissue, nerves, veins, arteries and connective
tissue that holds everything in place. Both breast tissue and connective tissue are denser
than fat. Previous studies showed that higher mammographic density is a strong risk factor
for breast cancer. In addition, age at menarche and age at first live birth are both known to
be associated with breast cancer. Women who have their first menstruation before age 12
have a slightly higher chance of developing breast cancer compared with those who have
their first period after 14; women who give birth to their first child at a young age tend
to have a relatively lower risk of developing breast cancer. Body mass index is another
risk factor for breast cancer. Before menopause, being slightly overweight can reduce
breast cancer risk. However, there is little existing work discussing the interrelationship
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between mammographic density, age at menarche, age at first live birth and body mass
index. The goal of our analysis is to investigate this interrelationship. Before implement-
ing our method, we used an inverse logistic transformation on mammographic density and
rescaled the other three risk factors to [0,1] by subtracting their minimums and dividing
by the ranges.
Preliminary analysis based on only the controls data showed that mammographic den-
sity is reasonably linear in age at menarche, age at first live birth and body mass index. To
check this, we fit both a linear regression model and a quadratic regression model using
controls and compared these two models via analysis of variance. The p-value is about
.78, which indicates the linear model is preferred over the quadratic model. Hence, we
adopted a linear m(·) in the secondary analysis. The diagnostic plots of linear regression
are given in Figure 3.1. The left plot is the kernel density estimate of the residuals from
a linear fit on the controls, with an overlaid normal density. It shows that the regression
error almost follows a normal distribution but with slightly negative skewness. The right
plot is the LOWESS smoother of fitted values versus the square roots of absolute values
of residuals, which indicates the regression error is homoscedastic.
The results of secondary analysis using only controls, Lin and Zeng’s parametric
method and our semiparametric approach based on 1000 bootstrap samples are given in
Table 3.3. All three methods have fairly consistent results as expected, since the regression
error is homoscedastic and close to normal. For all three methods, age at first live birth
is highly statistically significant with a positive effect on mammographic density. That is
women who gave birth to their first children earlier tend to have a lower mammographic
density, and hence obtain some protective effect from developing breast cancer. Both age
at menarche and body mass index have negative coefficients, which indicates that having
a relatively late first period or being moderately overweight can slightly reduce mammo-
graphic density. However, neither of them is statistically significant.
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As expected, Lin and Zeng’s parametric method has a much smaller bootstrap standard
deviation compared with the ordinary least squares using only controls, with an average
efficiency of 1.60. Here the efficiency is defined as the square of the ratio of bootstrap stan-
dard deviation compared with using only controls. Our semiparametric approach, which
assumes neither homoscedasticity nor normality, has almost the same bootstrap standard
deviation as Lin and Zeng’s method. The bootstrap standard errors of Lin and Zeng’s para-
metric approach for age at menarche, age at first live birth and body mass index are 0.131,
0.106, 0.138, respectively, while that of our semiparametric approach are 0.129, 0.107 and
0.137 respectively. The average efficiency of our approach is 1.63, which is even slightly
larger than that of Lin and Zeng’s method.
3.7 Discussion
We have extended the work of Ma and Carroll (2016) and have overcome the poten-
tial dimensionality issue involved in their nonparametric kernel regression. Multivariate
kernel regression is avoided by using dimension reduction modeling ideas. We repeat that
our work is not about fitting dimension reduction models per se, but to use them in the
secondary analysis of case-control studies. Our method makes no assumptions about the
regression errors, and we do not need to make a rare disease assumption or require known
disease rate.
The dimension reduction assumptions stated in (3.8)-(3.10) are mild in general, see
Proposition 1, and are applicable in many practical situations. An interesting topic for
future work would be to consider using regularization to further reduce the dimension of
Zβ so as to obtain an even more parsimonious model.
Alternative dimension reduction modeling approaches could exist, although it is not
easy to identify them based on our preliminary analysis along this line. For example,
generalized additive models do not appear to be suitable in the common regression error
40
structures described in Section 3.3.2. For example, in (3.8),
E{ǫ2κ(X, Y,α) | X} = E(ǫ2G[{XT,m(X,β)}(αT1 , α2)T + ǫα2] | X).
where G is a function of the logistic distribution function, i.e., a function of several expo-
nential functions. It is not clear that this can be written as a generalized additive model.
Even if it can be done, using such a dimension reduction approach will still require careful
exploration and new methodology development because off-the-shelf results on general-
ized additive models may not apply due to the case-control sampling nature.
Finally, in some cases, it might be possible to posit a parametric form for var(ǫ | X).
We believe that our approach can be extended to this case, and would further improve
efficiency in estimating β. This will be pursued in future work.
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Homoscedastic Gaussian error Heteroscedastic Gaussian error
β1 0.5 1.0 0.3 0.5 0.5 1.0 0.3 0.5
Controls
mean 0.514 0.977 0.280 0.480 0.543 0.940 0.254 0.433
s.d. 0.113 0.115 0.114 0.111 0.106 0.103 0.100 0.101
est. sd 0.114 0.113 0.113 0.113 0.102 0.102 0.102 0.102
95% 0.957 0.941 0.951 0.947 0.922 0.910 0.937 0.900
Param
mean 0.523 0.970 0.273 0.461 0.264 1.257 0.495 0.781
s.d. 0.082 0.085 0.087 0.084 0.089 0.083 0.088 0.086
est. sd 0.083 0.084 0.087 0.087 0.089 0.082 0.088 0.088
95% 0.948 0.942 0.933 0.932 0.250 0.115 0.406 0.101
MSE Eff 1.759 1.717 1.618 1.484 0.204 0.196 0.263 0.170
Semi
mean 0.507 0.992 0.292 0.493 0.510 0.986 0.289 0.484
s.d 0.089 0.088 0.086 0.087 0.102 0.093 0.092 0.098
est. sd 0.091 0.093 0.091 0.094 0.093 0.095 0.089 0.100
95% 0.960 0.964 0.961 0.975 0.932 0.957 0.936 0.950
MSE Eff 1.600 1.755 1.799 1.666 1.240 1.606 1.396 1.490
Table 3.1: Simulation study in Section 3.5 with N1 = 1, 000 cases and N0 = 1, 000
controls, disease rate of approximately 4.5% and 4-dimensional correlated covariates X
over 1,000 simulated data sets. The results for the homoscedastic normal error model are
listed on the left and the results for the heteroscedastic normal error model are listed on
the right. The three analyses performed are “Controls”, which is ordinary least squares
using only controls, “Param”, which is semiparametric efficient method proposed by Lin
and Zeng (2009) assuming normality and homoscedasticity, and “Semi”, which is our
new estimator described in Section 3.4. Here, we list the sample mean (“mean”), the
sample standard deviation (“s.d.”), the mean estimated standard deviation (“est. sd”) and
the coverage for the nominal 95% confidence intervals (“95%”) for all three methods. In
addition, we computed the mean squared error efficiency compared to using only controls
for the “Param” and “Semi” methods.
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Homoscedastic Gamma error Heteroscedastic Gamma error
β1 0.5 1.0 0.3 0.5 0.5 1.0 0.3 0.5
Controls
mean 0.522 0.967 0.277 0.470 0.581 0.902 0.228 0.394
s.d. 0.102 0.101 0.103 0.099 0.086 0.087 0.084 0.090
est. sd 0.100 0.100 0.100 0.100 0.087 0.087 0.087 0.087
95% 0.942 0.939 0.934 0.938 0.858 0.782 0.876 0.751
Param
mean 0.630 0.830 0.165 0.301 0.173 1.393 0.585 0.922
s.d. 0.135 0.135 0.135 0.135 0.144 0.124 0.127 0.137
est. sd 0.131 0.134 0.135 0.136 0.138 0.127 0.133 0.130
95% 0.820 0.750 0.831 0.691 0.368 0.124 0.427 0.105
MSE Eff 0.307 0.239 0.307 0.186 0.110 0.100 0.125 0.098
Semi
mean 0.502 0.995 0.299 0.501 0.513 0.981 0.291 0.482
s.d 0.068 0.068 0.067 0.068 0.084 0.081 0.073 0.088
est. sd 0.066 0.068 0.066 0.069 0.087 0.096 0.085 0.105
95% 0.948 0.958 0.947 0.955 0.948 0.958 0.953 0.946
MSE Eff 2.314 2.449 2.528 2.345 1.922 2.463 2.261 2.388
Table 3.2: Simulation study in Section 3.5 with N1 = 1, 000 cases and N0 = 1, 000
controls, disease rate of approximately 4.5% and 4-dimensional correlated covariates X
over 1,000 simulated data sets. The results for the homoscedastic gamma error model are
listed on the left and the results for the heteroscedastic gamma error model are listed on
the right. The three analyses performed are “Controls”, which is ordinary least squares
using only controls, “Param”, which is semiparametric efficient method proposed by Lin
and Zeng (2009) assuming normality and homoscedasticity, and “Semi”, which is our
new estimator described in Section 3.4. Here, we list the sample mean (“mean”), the
sample standard deviation (“s.d.”), the mean estimated standard deviation (“est. sd”) and
the coverage for the nominal 95% confidence intervals (“95%”) for all three methods. In
addition, we computed the mean squared error efficiency compared to using only controls
for the “Param” and “Semi” methods.
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Figure 3.1: Mammographic density data in Section 3.6. The left plot is the kernel density
estimate (solid black line) of the residuals from a linear fit on the controls, with an overlaid
normal density (dashed blue line). The right plot is the LOWESS smoother of fitted values





mean -0.047 0.428 -0.105
boot. sd 0.164 0.139 0.172
est. sd 0.165 0.144 0.176
Lower -0.371 0.146 -0.449
Upper 0.277 0.710 0.240
Param
mean -0.054 0.356 -0.121
boot. sd 0.131 0.106 0.138
est. sd 0.127 0.107 0.135
Lower -0.302 0.147 -0.385
Upper 0.195 0.565 0.144
Eff 1.550 1.710 1.547
Semi
mean -0.061 0.363 -0.135
boot. sd 0.129 0.107 0.137
est. sd 0.130 0.113 0.140
Lower -0.315 0.142 -0.410
Upper 0.194 0.584 0.140
Eff 1.606 1.698 1.575
Table 3.3: Analyses of the mammographic density data from the breast cancer detection
demonstration project (BCDDP) in Section 3.6, which has N1 = 2092 cases and N0 =
3295 controls, using only controls (“Controls”), Lin and Zeng’s method (“Param”) and
our approach (“Semi”). Displayed are the mean estimates of the coefficients for age at
menarche (MENARCHE), age at first live birth (1STLB) and body mass index (BMI),
their bootstrap standard deviation (“boot. sd”), the mean estimated bootstrap standard
deviation (“est. sd”) and the lower and upper end values of the 95% confidence intervals
(“Lower” and “Upper”). Also displayed is the efficiency (“Eff”), which is the square of
the ratio of bootstrap standard deviation to that using only controls.
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4. SEMIPARAMETRIC EFFICIENT ESTIMATION IN QUANTILE REGRESSION
OF SECONDARY ANALYSIS
4.1 Introduction
The secondary analysis we discussed in Section 3 focus on the association between
covariates X and Y based on the conditional mean function E(Y | X). However, in
epidemiological studies, it is often of interest to make inference for high or low values in
a population distribution. The reason is those high or low values are potentially associated
with high risks. For example, people with high body mass index and high blood pressure
are at a higher risk of developing diabetes (Wei et al., 2016). In such a case, quantile
regression, which provides a complete picture of the relationship between covariates and
secondary outcome at any percentile and is robust to the skewed distribution, is preferred
over conditional mean regression, which only describes the effect of the covariates on
the mean of the secondary outcome and is often sensitive to the misspecification of the
regression error distribution.
To our best knowledge, the weighted estimating equation (WEE) approach proposed
by Wei et al. (2016) is the first and the only approach on the secondary quantile regression.
The main idea of the WEE approach is to construct estimating equations that incorporate
both observed and pseudo counter-factual secondary outcomes, where the counter-factual
secondary outcomes refer to the pseudo outcomes under alternative disease status. The
WEE approach can be further classified into simulated counter-factual outcomes (SICO)
approach and kernel smoothing (KS) approach. The SICO approach simulates the counter-
factual outcomes directly and assembles the estimating equation, whereas the KS approach
replaces the counter-factual part of the estimating equation with its conditional expecta-
tion and thus avoids simulating pseudo outcomes. Their simulation result shows SICO
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approach with 100 replicates has comparable or better performance than KS approach and
IPW approach in terms of the mean squared error. Therefore, for comparison presented in
this work, we focus on the SICO approach.
The SICO method relies on the following two assumptions: (i) the disease rate in the
underlying source population is known, and (ii) the conditional quantile of the secondary
outcome is linear in X for any percentile. However, the disease rate in the source popula-
tion is not always available. Besides, as shown in the simulation study of Wei et al. (2016),
those two assumptions does not help SICO method gain much efficiency compared with
the controls only approach.
In this article, we propose to work under the hypothetical population framework (Ma,
2010; Ma and Carroll, 2016). Such a hypothetical population has the same case-to-control
ratio as the case-control sample and it allows us to view the case-control sample as a sam-
ple of independent identically distributed (i.i.d.) observations taken from this hypothetical
population. We further derive a class of semiparametric esimators by imposing a den-
sity function of Y given X, which is not necessarily to be the true density. The resulting
estimator is consistent. Moreover, it is efficient if the posited density is the truth.
The rest of the section is organized as follows. In Section 4.2, we introduce the sec-
ondary quantile regression model and the hypothetical population framework, and provide
necessary identifiability conditions. In Section 4.3, we construct the semiparametric ef-
ficient estimator through a conventional semiparametric approach. The implementation
of the resulting estimator is described in Section 4.4, while its asymptotic properties is
discussed in Section 4.5. In Section 4.6, we demonstrate the superiority of our semipara-
metric efficient estimator over existing approaches via various simulation studies. Section
4.7 illustrates the practical application of our approach through the analysis of a colorectal
cancer data set. Section 8 contains a short discussion. Technical details and proofs are
given in an Appendix.
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4.2 Model and Hypothetical Population Framework
4.2.1 Model
Let disease status be D, with D = 0 representing a control and D = 1 representing a
case. SetX be the exposures of interest, which can be either continuous, e.g., the first sev-
eral principle components of the non-genetic variables, or discrete, e.g., SNP information.
Other thanX, a secondary outcome Y is collected, which can be important biomarkers or
characterization of the disease. The disease risk is related to covariates X and Y through
a logistic regression model,
prtrue(D = d | X = x, Y = y) = H(d,x, y,α) = exp{d(αc +α
T
1 x+ α2y)}
1 + exp(αc +αT1 x+ α2y)
. (4.1)
Here and throughout the text, the superscript true is used to denote a model in the underly-
ing source population from which we obtain the case-control sample.
Let qτ,Y |X denote the τ
th conditional quantile of Y givenX. The secondary conditional
quantile model that represents the interrelationship between X and Y in the underlying
source population is given by
qtrueτ,Y |X(y,x, τ,βτ ) = βτ,c + x
Tβτ , (4.2)
where τ ∈ (0, 1). Model (4.2) can be alternatively written as
Y = βτ,c +X
Tβτ + ǫτ ,
where ǫτ has τ
th quantile zero, but its distribution is otherwise not specified. That is,∫
uτη2(ǫτ ,x)dǫτ = 0, where uτ ≡ I(ǫτ < 0) − τ , and η2(ǫτ ,x) denotes the density
function of ǫτ conditional on X = x in the true population, which has a unknown form.
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Besides, the distribution ofX is also unspecified.
Suppose we draw a case-control sample with n1 cases and n0 controls from the un-
derlying source population model (4.1) - (4.2). That is, we assume that the source pop-
ulation can be split into a disease population and a disease-free population, which we
call case subpopulation and control subpopulation, respectively. We then sample n1 cases
randomly from the case subpopulation and n0 controls randomly from the control subpop-
ulation. Typically, n1 and n0 are chosen to be comparable in practice. As a result, the
case-to-control ratio in the case-control sample is usually higher than it is in the underly-
ing source population. Subsequently, the association betweenX and Y in the case-control
sample may differ dramatically from the association in the underlying source population.
To understand this numerically, we set α = (αc,α1, α2) = (−4.5, 1, 1) in the logis-
tic regression model (4.1) and τ = 0.5,β = (βc,βτ ) = (0, 1) in the secondary quantile
regression model (4.2). Additionally, we simulateX from Uniform(0,1) and ǫτ from Nor-
mal(0,1). The resulting disease rate is about 5%. From this specific setting, we generated
1,000 case-control data sets, each consists of 500 cases and 500 controls. We then ran
quantile regression on each of the simulated data sets, ignoring the case-control sampling
scheme, and averaged the estimated slope and intercept across all 1,000 simulations. The
result is summarized in Figure 4.1. The dashed blue line is the quantile regression rela-
tionship between covariateX and secondary outcome Y under the case-control context. It
has an intercept of 0.225 and slope of 1.352. The solid black line is the relationship in the
underlying source population, which has an intercept of 0 and slope of 1. Clearly, neglect-
ing the retrospective nature of the case-control sample produce bias in both intercept and
slope.
As illustrated by the artificial example given above, the main difficulty in secondary
analysis is that the case-control sample is not a representative sample of the underlying
source population. To conquer this problem, we borrow strength from the hypothetical
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population framework used in Ma (2010); Ma and Carroll (2016). Such a hypothetical
population has the same case-to-control ratio as the case-control sample. It is connected
with the true population through the fact that they are identical given the disease status.
Ma (2010) proved the first order asymptotic equivalence between the case-control sam-
pling and random sampling in the hypothetical population. Her result permits us to view
the case-control sample as a prospective random sample taken from this hypothetical popu-
lation. The exact form of the hypothetical population for the secondary quantile regression
problem we are studying is given in Section 4.2.2.
4.2.2 Hypothetical Population
We consider the case that the disease rate in the true population, π1 ≡ prtrue(D = 1),




T and β = (βc,β
T
τ )
T. Using the concept of hypothetical population
(Ma, 2010), we treat the case-control sample as a random sample from a hypothetical
population, where the disease and non-disease ratio is n1/n0. For a random observation of
the hypothetical population (X, Y,D), its density function has an explicit form,
fX,Y,D(x, y, d,βτ ,α, η1, η2)











η1(x)η2(ǫτ ,x)f trueD|X,Y (d,x, y,α)dµ(x)µ(y)
=
ndη1(x)η2(y − βτ,c − xTβτ ,x)H(d,x, y,α)
n
∫
η1(x)η2(y − βτ,c − xTβτ ,x)H(d,x, y,α)dµ(x)µ(y) , (4.3)
where n = n0 + n1, µ denotes a Lebesgue measure for a continuous random variable and
a counting measure for a discrete random variable. η1 and η2 are the respective probability





η2(ǫτ ,x)dµ(ǫτ ) = 1, and
∫
uτη2(ǫτ ,x)dµ(ǫτ ) = τ . However,
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f trueY to emphasize they are infinite-dimensional nuisance parameters.
Under the hypothetical population framework (4.3), we obtain a locally efficient semi-
parametric estimator for α and β using a geometric approach illustrated in Bickel et al.
(1993) and Tsiatis (2007). A sketch of the approach is given in Section 4.3 while its
technical details are given in Appendix C.4 and C.5.
Remark 3. It is known that a consistent estimator of α excluding αc can be obtained via
the prospective logistic regression, treating the case-control sample as if it is a random
sample. We can then plug in the estimator of α excluding αc, and focus on estimating β
and αc only. Here we choose to treat the estimation of α and β together instead.
4.2.3 Identifiability
Before introducing our locally efficient semiparametric estimator, it is useful to study
the identifiability of α and β in the hypothetical population. We assume the following
conditionds.
Assumption 1. For any δ > 0, there exists K > 0 such that limxℓ→±∞ pr(ǫτ < −K |
x) < δ, where xℓ is the ℓth element of x.
Assumption 2. α1 + βτα2 6= 0 and α2 6= 0.
Assumption 1 ensures the left tail of ǫτ given x is not too heavy when an arbitrary
element of x diverges to ±∞. This is a natural condition to guarantee the mean signal
βc+X
Tβτ can be separated from the noise ǫτ . Assumption 2 ensures the logistic regression
model (4.1) indeed depends on the value of β. When it is violated, we can prove βτ is
still identifiable, but βc and αc are no longer identifiable. See Appendix C.2 and C.3 for
details.
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The identifiability result is stated in Proposition 2 below, while its proof is provided in
Appendix C.1.
Proposition 2. Under Assumptions 1-2, the parameter α and βτ are identifiable.
4.3 Analytical Derivation
Let θ = (αT,βT)T, and η = (η1, η2). Define p = dim(θ). The hypothetical popu-
lation model (4.3) is a semiparametric model, where θ is a finite-dimensional parameter
we are interested in, and η is an infinite-dimensional nuisance parameter. One general
approach to handle such a semiparametric problem is to find a p-dimensional influence
function φ(X, Y,D;θ, η), i.e., an arbitrary function with mean E{φ(X, Y,D;θ, η)} = 0,
and solve the corresponding estimating equation
∑n
i=1 φ(Xi, Yi, Di;θ, η) = 0. The re-
sulting estimator is a semiparametric estimator with variance var{φ(X, Y,D;θ, η)}. For
instance, the score function of the hypothetical population (4.3), Sθ = S − E(S | d), is a
valid influence function that leads to a semiparametric estimator. Here
S(x, y, d,θ, η2) =
 ∂logH(d,x, y,α)/∂α




η2(ǫτ ,x)dǫτ = 1 and Etrue(uτ | x) =
∫
uτη2(ǫτ ,x)dǫτ = 0. In
fact, S is the score function of the underlying source population. Among the class of
all semiparametric estimators, the optimal estimator, which is usually referred to as the
semiparametric efficient estimator, is the one with smallest variance.
We adopt a geometric approach (Bickel et al., 1993; Tsiatis, 2007) to drive the semi-
parametric efficient estimator. Specifically, we consider a Hilbert spaceH that consists of
of all p-dimensional measurable functions with mean zero and finite variance and define
the inner product of two arbitrary functions in H to be their covariance. We then decom-
pose the Hilbert space H as H = Λ ⊕ Λ⊥, where Λ is the nuisance tangent space and Λ⊥
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is the orthogonal complement of Λ. The semiparametric efficient estimator can be solved
from
∑n
i=1 Seff(Xi, Yi, Di;θ, η) = 0, where Seff is the projection of the score function Sθ
onto Λ⊥. Consequently, Seff is usually called the efficient score function.
Under the hypothetical population model (4.3), the nuisance tangent space has the form
Λ = [g(ǫτ ,x)− E{g(ǫτ ,X) | d} : Etrue(g) = 0, Etrue{uτg(ǫτ ,x) | x} = 0, a.s.] ,
where ǫτ = Y − βc − xTβτ . Its orthogonal complement is






= a(x)uτ , a.s. ∀a
]
.
The detailed derivation of Λ and Λ⊥ is provided in Appendix C.4.
The projection of the score function Sθ onto Λ
⊥ is very mathematically involved. Here
we list the final form of the efficient score function Seff , while deferring all the technical
details to Appendix C.5. Particularly,
Seff(X, Y,D;θ, η) = S(X, Y,D;θ, η)− g(Y − βc −XTβτ ,X)− (1−D)v0 −Dv1,
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where
π0 ≡ prtrue(D = 0) =
∫
η1(x)η2(ǫτ ,x)H(0,x, y)dµ(x)dµ(y);
π1 ≡ prtrue(D = 1) =
∫
η1(x)η2(ǫτ ,x)H(1,x, y)dµ(x)dµ(y);
b0 ≡ E{fD|X,Y (1,X, Y ) | D = 0}; b1 ≡ E{fD|X,Y (0,X, Y ) | D = 1};
c0 ≡ E(S | D = 0)− E{E(S | ǫτ ,X) | D = 0};
c1 ≡ E(S | D = 1)− E{E(S | ǫτ ,X) | D = 1};
κ(x, y) ≡ [∑1d=0{ndH(d,x, y)}/(nπd)]−1; t1(x) ≡ [Etrue {u2τκ(X, Y ) | x}]−1;
t2(x) ≡ Etrue {uτE(S | ǫτ ,x) | x} − (c0/b0)Etrue
{
uτfD|X,Y (0,x, Y ) | x
}
;
t3(x) ≡ −b−10 Etrue
{
uτfD|X,Y (0,x, Y ) | x
}
; a(x) ≡ t1(x){t2(x) + t3(x)u0};
u0 ≡ (1− E [uτ t1(X)t3(X)κ(X, Y ) | D = 0])−1E [uτ t1(X)t2(X)κ(X, Y ) | D = 0];
u1 ≡ −(n0/n1)u0;v0 ≡ (π1/b0)(u0 + c0);v1 ≡ −(π0/b0)(u0 + c0);
g(ǫ,x) ≡ E(S | ǫτ ,x)− uτa(x)κ(x, y)− v0fD|X,Y (0,x, y)− v1fD|X,Y (1,x, y).
(4.5)
The semiparametric efficient estimator is then obtained by solving
∑N
i=1{S(Xi, Yi, Di)− g(Yi −XTi βτ ,Xi)} − n0v0 − n1v1 = 0. (4.6)
The estimating equation (4.6) involves the disease and non-disease rate, π1 and π0 =
1− π1, which are assumed to be unknown. We notice that
π0 =
∫

















n0H(0,X, Y,α)/π0 + n1H(1,X, Y,α)/(1− π0)
]
. (4.7)
Moreover, π0 = pr
true(D = 0) is the unique solution to equation (4.7) if pr{H(0,X, Y,







n0H(0,Xi, Yi,α)/π0 + n1H(1,Xi, Yi,α)/(1− π0) .
Denote the resulting estimator by π̂0. We then estimate π1 by π̂1 = 1− π̂0.
4.4 Algorithm
Some other quantities involved in the estimating equation (4.6) depends on the un-
known distributions of X and Y | X, i.e., η1 and η2. All those quantities can be estimated
nonparametrically if we know the exact form of the score function in the underlying source
population, i.e., S, which is defined in (4.4). Unfortunately, S itself also relies on the un-
known probability density function η2. Here, we propose an algorithm based on a posited
score function S∗. It is obtained by replacing η2 with an arbitrary density function with
τ th quantile zero in (4.4). The resulting estimator of θ is locally efficient.
Here is the detailed algorithm.
1. Posit a model for η2(ǫτ ,x) which has τ th quantile zero, and calculate (4.4), calling
the result S∗.
2. Solve π̂0 =
∑N
i=1H(0,Xi, Yi){n0H(0,Xi, Yi)/π̂0 + n1H(1,Xi, Yi)/(1− π̂0)}−1 to
obtain π̂0.
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3. Set π̂1 = 1− π̂0 and
κ̂i = κ̂(Xi, Yi) = {
∑
dndH(d,Xi, Yi)/(nπ̂d)}−1
f̂0i = f̂D|X,Y (0,Xi, Yi) = n0H(0,Xi, Yi)κ̂i/(nπ̂0)
f̂1i = f̂D|X,Y (1,Xi, Yi) = n1H(1,Xi, Yi)κ̂i/(nπ̂1)
µ̂si = Ê(S
∗





















i=1 {S∗(1,Xi, Yi)− µ̂si} f̂1i/
∑N
i=1f̂1i.
4. Perform a nonconventional weighted version of the nonparametric regression to
form Êtrue(u
2









i=1I(Di = d)Kh(Xi − x)} and t̂1(x) = {Êtrue(u2τ κ̂ | x)}−1.
5. (a) Perform nonparametric regression using the data (Xi, uτ,iµ̂si) with Di = 0
to obtain Ê(uτ µ̂s | x, D = 0). Similarly, perform nonparametric regression
using the data (Xi, uτ,iµ̂si) with Di = 1 to obtain Ê(uτ µ̂s | x, D = 1).
(b) Form Êtrue(uτ µ̂s | x) =
∑
dπ̂dÊ(uτ µ̂s | x, D = d)f̂X|D(x, d)/
∑
dπ̂df̂X|D(x, d).
6. (a) Perform nonparametric regression using the data (Xi, uτ,if̂0i) with Di = 0 to
obtain Ê(uτ f̂0 | x, 0). Similarly, perform nonparametric regression using the
data (Xi, uτ,if̂0i) with Di = 1 to obtain Ê(uτ f̂0 | x, 1).
(b) Form Êtrue(uτ f̂0 | x) =
∑
dπ̂dÊ(uτ f̂0 | x, d)f̂X|D(x, d)/
∑
dπ̂df̂X|D(x, d).
7. (a) Perform nonparametric regression using the data (Xi, uτ,if̂1i) with Di = 0 to
obtain Ê(uτ f̂1 | x, 0). Similarly, perform nonparametric regression using the
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data (Xi, uτ,if̂1i) with Di = 1 to obtain Ê(uτ f̂1 | x, 1).
(b) Form Êtrue(uτ f̂1 | x) =
∑
dπ̂dÊ(uτ f̂1 | x, d)f̂X|D(x, d)/
∑
dπ̂df̂X|D(x, d).
8. (a) Form t̂2(x) = Êtrue(uτ µ̂s | x)− (ĉ0/b̂0)Êtrue(uτ f̂0 | x) and t̂3(x) = −b̂−10
× Êtrue(uτ f̂0 | x).










i=1f̂0i and û0 =
[
1− Ê {uτ t1(x)t3(x)κ(x, y) | D = 0}
]−1
× Ê {uτ t1(x)t2(x)κ(x, y) | D = 0}.
(c) Form û1 = −(n0/n1)û0, v̂0 = (π̂1/b̂0)(û0+ ĉ0) and v̂1 = −(π̂0/b̂0)(û0+ ĉ0).
(d) Form â(x) = t̂1(x){t̂2(x) + t̂3(x)û0}.
(e) Form ĝi = µ̂si − uτ,iâ(Xi)κ̂i − v̂0f̂0i − v̂1f̂1i.
(f) Form Ŝ∗eff(Di,Xi, Yi) = S
∗
i − ĝi− v̂Di and solve the corresponding estimating
equation.
We point out the algorithm described above is designed for continuousXi. WhenXi is
discrete, one simply replaces the various nonparametric regressions with the correspond-
ing averages associated with the different xi values.
4.5 Asymptotics
The asymptotic distribution of the proposed estimator is given in Theorem 4 below,
with proof provided in Appendix C.6. We assume the following regularity conditions.
C1: There exists a constant 0 < C <∞ such that limn→∞ n1/n2 = C.
C2: The univariate kernel function is a probability density function with support (−1, 1)
and order r, i.e.,
∫
K(x)xtdx = 0 if 1 ≤ t < r and ∫ K(x)xrdx 6= 0. The d-
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dimensional kernel function, still represented with K, is a product of d univariate
kernel functions, that is, K(x) =
∏d
i=1K(xi) for a d-dimensional x.
C3: For d = 1, 0, fX|D(x | D = d), E(u2τκ | X, D = d), E(uτµs | X, D = d), E(uτf0 |
X, D = d), E(uτf1 | X, D = d) have compact support and have continuous rth
derivatives.
C4: The bandwidth h = n−τ where 1/(2d) > τ > 1/(4r), where d is the dimension of
x. This allows the optimal bandwidth h = O{n−1/(2r+d)} as long as we choose a
kernel of order 2r > d.
The preceding regularity conditions are typical assumptions to ensure the consistency
of the nonparametric estimators built in Section 4.4 and the subsequent semiparametric es-
timator of θ. Specifically, condition C1 is a general assumption in all case-control studies
of the type we are considering. It ensures the number of cases and controls are compara-
ble in the case-control sample. Condition C2 and C4 are standard requirements on kernel
functionK and bandwidth h. Condition C3 is the smoothness assumption on the functions
that are needed to be estimated nonparametrically.
Theorem 4. Under the regularity conditions C1-C4 listed above, the estimator θ̂ obtained




eff(Di,Xi, Yi, θ̂) = 0 satisfies
n1/2(θ̂ − θ)→ Normal{0,A−1B (A−1)T}
when n→∞, whereA = E {∂S∗eff(D,X, Y,θ)/∂θT} and B = cov {S∗eff(D,X, Y,θ)}.
4.6 Simulation Study
In this section, we study the finite sample performance of our estimator via various
simulations. Specifically, we considered the following 54 simulation settings. First, we
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consider a relatively rare disease rate of 4.5%, an extremely rare disease rate of 1%, and
a common disease rate of 10%. Second, we set the secondary model to be Y = β0 +
β1X + ǫτ , where β0 = 0.5 and β1 = 1, and generate X from a Uniform(0,1) distribution.
In the secondary model, we consider three different quantiles τ = 0.25, 0.5, and 0.75,
corresponding to first quartile, median, and third quartile, respectively. In addition, we
consider three different regression error distributions. Specifically, we first generate ǫ∗ ∼
F , and then set the regression error ǫ = {ǫ∗ − F−1(τ)}(1 + X2)3/4/2, where F is the
standard normal distribution Normal(0, 1), or the standardized Gamma distribution with
shape parameter 0.4. Third, the logistic regression model was pr(D = 1|Y,X) = H(αc +
α1X + α2Y ), where α1 = 1 and α2 = 0.50. The intercept αc is chosen to achieve specific
disease rates given above.
For each setting, we simulated 1,000 data sets, each with 1,000 cases and 1,000 con-
trols, and applied the algorithm discussed in Section 4.4. Specifically, we set the posited
model for η2 to be Normal{−Φ−1(τ), 1}, where Φ is the distribution function of the stan-
dard normal distribution. It is easy to check the τ th quantile of the posited model is zero,
and the second element in S∗ has a simple and clear form, {y−βc−βτx+Φ−1(τ)}(1, x)T.
Note that the posited model for η2 is misspecified because we simulate the regression er-
ror from normal distribution and gamma distribution with heteroscedastic variance. When
performing the nonparametric regressions, we use a bandwidth h = cn
−1/3
0 , where c is a
constant and n0 is the number of controls. We have tested the performance of our estimator
using different values of c between 0.5 and 1.5 and found out the results are similar. Here
we only report the result with c = 1.
We contrasted our locally efficient semiparametric approach, refered to as “Semi”,
with two methods. The first one is the ordinary quantile regression on only controls,
which we refer to as “Controls”. It produces estimators with negligible bias when the dis-
ease rate is rare. The second one is the SICO approach by Wei et al. (2016), which forms a
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weighted estimating equation by combining both observed secondary outcomes and unob-
served counter-factual secondary outcomes simulated under an alternative disease status.
Because simulating counter-factual secondary outcomes brings extra variability into the
SICO estimator, Wei et al. (2016) suggested to stabilize their estimator by replication.
Here we use 100 replicates in all the simulations. Besides, the SICO approah requires
a known disease rate. We passed the true disease rate, i.e., 1% for the cases with an ex-
tremely rare disease rate, 4.5% for the cases with a relatively rare disease rate, and 10% for
the cases with a common disease rate, to the SICO approach, and refered to the resulting
estimator as “SICO, true”. To check the robustness of SICO approach to the misspecifica-
tion of the disease rate, we also passed a rare disease rate of 1% to the SICO approach for
the cases with a true disease rate of 4.5% and 10%. The resulting estimator is refered to
as “SICO, rare”.
The results are summarized in Table 4.1-4.3. We display three key features, i.e., the
mean estimates, the standard deviation across the simulation, and the mean squared error
efficiency (MSE Eff) of SICO approach and our semiparametric approach relative to using
only controls. A notable finding is, our locally efficient semiparametric estimator, which
does not assume a known or rare disease rate, shows dominating advantages over the
controls only approach and SICO approach in terms of the mean squared error. Besides,
the SICO rare approach suffers from inflated bias and variability when the true disease rate
is 10%.
Specifically, in the case of an extremely rare disease of 1% (Table 4.1), all three ap-
proaches showed asymptotical consistency with small bias. However, the SICO approach
using the true disease rate has a maximum MSE Eff of 1.083 and 1.052 for the cases with
heteroscedastic normal error and gamma error, respectively. That is, the efficiency gain of
SICO approach over the controls only approach is marginal. In contrast, our approach has
a minimum MSE Eff of 3.194 for the heteroscedastic normal case, and a minimum MSE
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Eff of 2.680 for the heteroscedastic gamma case.
As the disease rate increased to 4.5% and 10% (Table 4.2 - 4.3), the controls only ap-
proach showed moderate bias, epecially for the slope βτ , so is the SICO rare approach.
Meanwhile, the SICO true approach and our semiparametric approach remained consis-
tent. Besides, compared to the controls only approach, the SICO rare approach has sim-
ilar efficiency and the SICO true approach has slightly better efficiency. In contrast, our
semiparametric estimator remains two to five times more efficient than the controls only
approach. Take the case with 10% disease rate, quantile τ = 0.75, and heteroscedastic
gamma regression error as an example and focus on the estimates of βτ . Both the con-
trols only estimator and the SICO rare estimator have more than 7% bias, while the SICO
true estimator and our semiparametric estimator have no more than 2% bias. Moreover,
the SICO rare and SICO true estimator have a respective MSE Eff of 1.078 and 1.718,
whereas our semiparametric has a MSE Eff of 5.605.
4.7 Real Data Analysis
The consumption of red meat, e.g., beef, is known to be positively associated with
colorectal cancer. Although red meat can provide necessary nutritions such as protein,
vitamins, and minerals, it can also produce MeIQx, a carcinogenic heterocyclic amine
(HCA), if cooked at high temperatures for long duration. Besides, red meat may also be
connected with colorectal cancer through other nutrition facts such as saturated fat and
cholesterol. Analyzing the relationship between red meat and MeIQx may yield valuable
insights about the etiology of colorectal cancer.
In this section, we apply our locally efficient semiparametric approach to a case-control
data set of colorectal adenoma, taken from a large population-based cohort study, the
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO). The PLCO co-
hort study recruited a total of 33,971 participants, 10% of which were cases, i.e., par-
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ticipants developed at least one histologically verified colorectal adenoma (Peters et al.,
2003). n1 = 640 cases and n0 = 665 controls were randomly taken from the case sub-
group and control subgroup of this cohort study, respectively, and formed a case-control
data set.
In our analysis, we set X to be the red meat consumption in grams and Y to be the
MeIQx produced during the cooking in nanograms per gram of red meat. Because both
X and Y are heavily skewed in their original measurement scales, we transformed X and
Y by first adding 1.0 and taking logrithms, and then dividing their respective standard
deviations. We fit model (4.1) and (4.2) to this case-control data set with τ = 0.5 using
three approaches, i.e., controls only approach, SICO approach, and our semiparamtric
approach described in Section 4.4. Although the true disease rate π1 is known, we feed
the SICO approach with an extremely rare disease rate of 1%, a rare disease rate of 4.5%,
and a true disease rate of 10%. In contrast, our locally efficient semiparametric approach
is applied assuming the disease rate is unknown.
The result is summarized in Table 4.4. All three approaches showed there is a positive
association between red meat consumption and the MeIQx, or equivalently, high assump-
tion of red meat leads to high intake of MeIQx. Besides, the SICO estimator with 1%
disease rate has marginal improvement in efficiency compared with controls only estima-
tor, in line with expectations. Here efficiency is defined as the ratio of variance relative to
the controls only estimator. While the inputted disease rate increases, the efficiency of the
SICO approach gets enhanced and it achieves the maximum efficiency at the true disease
rate π1 = 10%. In comparison, our semiparametric estimator, which assume the disease
rate to be unknown, has the greatest efficiency among all three estimators.
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4.8 Discussion
The quantile regression is often preferred in epidemiology, especially when it is of in-
terest to make inference about the high or low values of the population. In this article, we
considered the secondary quantile regression problem with minimal model assumptions.
Particular, we only specify a linear relationship between covariates at a given quantile
in the secondary model, while the covariate distribution is modeled completely nonpara-
metric. We showed that despite of these weak assumptions, the problem is identifiable
excluding a few cases. Under those weak assumptions, we developed a class of consis-
tent semiparametric estimators and identified the most efficient member by adopting the
hypothetical population framework and viewing the case-control sample as a prospective
random sample taken from the hypothetical population (Ma, 2010). The utilization of
the hypothetical population permits the application of a conventional semiparametric ap-
proach; however, the derivation is highly non-standard and non-trivial. The superiority of
our semiparametric estimator is demonstrated both theoretically and numerically.
The implementation of algorithm discussed in Section 4.4 involves several nonpara-
metric regression, which meets the curse of dimensionality when the dimension of covari-
ates increases. One possible future work is employing dimension reduction techniques
such as single index model or B-spline in the secondary quantile regression model.
Another compelling direction is to further improve the efficiency of our locally efficient
semiparametric estimator by imposing certain parametric structure on the regression error
ǫτ , say ǫτ = X
Tζǫ∗τ , where ǫ
∗
τ has τ
th quantile zero. The general methodology of our
approach can definitely be extended here, but the asymptotic property of the resulting
estimator would need to be re-established.
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τ = 0.25 τ = 0.5 τ = 0.75
β 0.5 1.0 0.5 1.0 0.5 1.0
Normal
Controls
mean 0.501 0.988 0.501 0.988 0.501 0.987
s.d. 0.063 0.119 0.056 0.107 0.063 0.119
SICO, true
mean 0.502 0.992 0.501 0.993 0.501 0.994
s.d 0.062 0.116 0.055 0.105 0.061 0.115
MSE Eff 1.048 1.056 1.043 1.060 1.062 1.083
Semi
mean 0.496 1.002 0.498 1.003 0.500 1.003
s.d 0.034 0.055 0.032 0.053 0.032 0.051
MSE Eff 3.368 4.764 3.194 4.180 3.807 5.520
Gamma
Controls
mean 0.500 1.000 0.502 0.994 0.502 0.990
s.d. 0.006 0.012 0.021 0.042 0.056 0.114
SICO, true
mean 0.500 1.000 0.501 0.997 0.502 0.998
s.d 0.005 0.011 0.021 0.041 0.055 0.111
MSE Eff 1.042 1.042 1.030 1.046 1.047 1.052
Semi
mean 0.499 1.000 0.501 1.000 0.504 1.004
s.d 0.003 0.005 0.013 0.023 0.032 0.056
MSE Eff 3.828 4.954 2.680 3.288 3.119 4.121
Table 4.1: Simulation study in Section 4.6 with n1 = 1, 000 cases and n0 = 1, 000 con-
trols, and a disease rate of approximately 1% over 1,000 simulated data sets. The results
for the heteroscedastic normal error model are listed on the top and the results for the het-
eroscedastic gamma error model are listed at the bottom. The three analyses performed
are “Controls”, which is quantile regression using only controls, “SICO, true”, which is
simulated counter-factual outcomes approach proposed by Wei et al. (2016) assuming the
true disease rate is known, and “Semi”, which is our new estimator described in Section
4.4. Here, we list the sample mean (“mean”), the sample standard deviation (“s.d.”), and
the mean squared error efficiency compared to using only controls (“MSE Eff”).
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τ = 0.25 τ = 0.5 τ = 0.75
β 0.5 1.0 0.5 1.0 0.5 1.0
Normal
Controls
mean 0.499 0.976 0.498 0.974 0.500 0.967
s.d. 0.064 0.120 0.058 0.106 0.064 0.119
SICO, true
mean 0.499 0.999 0.499 0.999 0.501 0.996
s.d 0.061 0.113 0.056 0.101 0.061 0.112
MSE Eff 1.092 1.170 1.082 1.176 1.111 1.230
SICO, rare
mean 0.499 0.981 0.498 0.980 0.500 0.974
s.d 0.062 0.117 0.057 0.105 0.063 0.116
MSE Eff 1.043 1.067 1.034 1.058 1.042 1.082
Semi
mean 0.496 1.008 0.497 1.006 0.500 1.002
s.d 0.036 0.059 0.033 0.053 0.032 0.052
MSE Eff 3.137 4.245 3.144 4.273 4.046 5.675
Gamma
Controls
mean 0.501 0.999 0.501 0.990 0.500 0.970
s.d. 0.006 0.011 0.021 0.043 0.053 0.107
SICO, true
mean 0.501 1.000 0.500 0.999 0.499 1.002
s.d 0.005 0.011 0.020 0.042 0.051 0.104
MSE Eff 1.071 1.095 1.065 1.120 1.063 1.163
SICO, rare
mean 0.501 0.999 0.501 0.992 0.500 0.976
s.d 0.005 0.011 0.021 0.042 0.052 0.105
MSE Eff 1.041 1.053 1.034 1.049 1.040 1.073
Semi
mean 0.499 1.000 0.501 1.000 0.502 1.008
s.d 0.003 0.005 0.013 0.024 0.029 0.050
MSE Eff 3.601 4.620 2.549 3.347 3.335 4.789
Table 4.2: Simulation study in Section 4.6 with n1 = 1, 000 cases and n0 = 1, 000 con-
trols, and a disease rate of approximately 4.5% over 1,000 simulated data sets. The results
for the heteroscedastic normal error model are listed on the top and the results for the
heteroscedastic gamma error model are listed at the bottom. The four analyses performed
are “Controls”, which is quantile regression using only controls, “SICO, true”, which is
simulated counter-factual outcomes approach proposed by Wei et al. (2016) assuming the
true disease rate is known, “SICO, rare”, which is simulated counter-factual outcomes
approach assuming a rare disease rate of 1%, and “Semi”, which is our new estimator
described in Section 4.4. Here, we list the sample mean (“mean”), the sample standard
deviation (“s.d.”), and the mean squared error efficiency compared to using only controls
(“MSE Eff”).
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τ = 0.25 τ = 0.5 τ = 0.75
β 0.5 1.0 0.5 1.0 0.5 1.0
Normal
Controls
mean 0.501 0.941 0.494 0.948 0.496 0.942
s.d. 0.062 0.118 0.058 0.108 0.061 0.115
SICO, true
mean 0.502 0.992 0.497 1.001 0.500 1.000
s.d 0.058 0.106 0.053 0.096 0.056 0.101
MSE Eff 1.166 1.538 1.183 1.556 1.205 1.626
SICO, rare
mean 0.500 0.947 0.494 0.953 0.496 0.948
s.d 0.061 0.115 0.057 0.106 0.060 0.113
MSE Eff 1.050 1.084 1.038 1.081 1.038 1.078
Semi
mean 0.498 1.009 0.499 1.006 0.500 1.007
s.d 0.033 0.056 0.031 0.048 0.032 0.049
MSE Eff 3.480 5.523 3.502 6.211 3.696 6.867
Gamma
Controls
mean 0.500 0.997 0.502 0.976 0.502 0.921
s.d. 0.005 0.010 0.021 0.041 0.054 0.105
SICO, true
mean 0.500 1.000 0.502 0.992 0.501 0.980
s.d 0.005 0.010 0.020 0.039 0.051 0.098
MSE Eff 1.110 1.225 1.105 1.442 1.108 1.718
SICO, rare
mean 0.500 0.997 0.502 0.978 0.502 0.927
s.d 0.005 0.010 0.020 0.040 0.053 0.103
MSE Eff 1.039 1.061 1.035 1.070 1.032 1.078
Semi
mean 0.499 1.001 0.502 0.999 0.503 1.007
s.d 0.003 0.005 0.012 0.023 0.030 0.055
MSE Eff 3.188 4.111 2.774 4.277 3.144 5.605
Table 4.3: Simulation study in Section 4.6 with n1 = 1, 000 cases and n0 = 1, 000 con-
trols, and a disease rate of approximately 10% over 1,000 simulated data sets. The results
for the heteroscedastic normal error model are listed on the top and the results for the
heteroscedastic gamma error model are listed at the bottom. The four analyses performed
are “Controls”, which is quantile regression using only controls, “SICO, true”, which is
simulated counter-factual outcomes approach proposed by Wei et al. (2016) assuming the
true disease rate is known, “SICO, rare”, which is simulated counter-factual outcomes
approach assuming a rare disease rate of 1%, and “Semi”, which is our new estimator
described in Section 4.4. Here, we list the sample mean (“mean”), the sample standard
deviation (“s.d.”), and the mean squared error efficiency compared to using only controls
(“MSE Eff”).
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Figure 4.1: Artificial example discussed in Section 4.2.1. The solid black line is the rela-
tionship between covariate X and secondary outcome Y in the underlying source popula-
tion; the dashed blue line is the relationship under the case-control context; the dashed red
line is the regression function among only controls.
β0 βX
mean sd Eff mean sd Eff
Controls -3.607 0.194 1.000 0.732 0.039 1.000
SICO, 1% -3.605 0.185 1.098 0.732 0.037 1.087
SICO, 4.5% -3.595 0.178 1.185 0.730 0.036 1.175
SICO, 10% -3.583 0.170 1.306 0.728 0.034 1.303
Semi -3.529 0.159 1.494 0.721 0.031 1.537
Table 4.4: Results of the secondary analysis of the colorectal adenoma data set discussed in
Section 4.7 across 1,000 bootstrap samples: “Controls" is the quantile regression on only
controls, “SICO" is the simulated counter-factual outcomes approach by Wei et al. (2016),
and “Semi" is our locally efficient semiparametric approach. The “SICO" approach is
fitted using three different disease rates, 1%, 4.5%, and 10%, while the “Controls" and
“Semi" approaches are fitted without specifying the disease rate. Mean (“mean"), sample
standard deviation (“sd"), and the square of the ratio of the sample standard deviation
compared to controls only approach (“Eff") are reported.
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5. CONCLUSION
Semiparametric theory framework is of substantial value in dealing with a vast major-
ity of statistical problems, where the objective is to estimate a finite-dimensional param-
eter, which is practically important, in the presence of an infinite-dimensional nuisance
parameter, which is often complex and of no interest. Three semiparametric models gen-
erally used in primary and secondary analysis of case-control studies are considered in
this dissertation, i.e., (a) the gene-environment interaction model under independence as-
sumption, (b) the secondary conditional mean regression model, and (c) the secondary
conditional quantile regression model. The direct use of the semiparametric theory, which
works for i.i.d. samples, in case-control studies, where the samples are biased and taken in
a retrospective way, is invalid. We extend the semiparametric framwork to the case-control
studies and derive novel semiparametric estimators by adopting a hypothetical population
framework and viewing the case-control sample as a prospective random sample generated
from the hypothetical population.
Prior to this work, existing approaches exploit gene-environment independence as-
sumption in the gene-environment interaction model either restrict the disease rate to be
rare or require distributional assumptions on genetric variables, and hence are not applica-
ble when those assumptions are violated. In this work, we obtain the efficient semipara-
metric estimator, i.e., a semiparametric estimator that is root-N consistent and asymptoti-
cally normal with minimal variance, under a flexible semiparametric model that allows the
disease rate to be unknown and the distribution of both genetic and environment variables
to be unspecified. Besides, we provide the asymptotic variance of our semiparametric ef-
ficient estimator, which can be used for inference. Various simulations with a wide range
of disease rates and a group of distinct covariate distributions reveal the eminence of our
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approach compared with the prospective logistic regression. Moreover, in the real data
analysis in Section 2.6, our method detects statistically significant interaction between
[25(OH)D] level and VDR gene on the prostate cancer while the prospective logistic re-
gression concludes the interaction term is not significant. Future work entails exploring
dimensional reduction approaches, such as single-index modeling and B-spline, to deal
with the dimensionality problem arised in nonparametric regression.
In the secondary conditional mean regression model, we devise a dimension reduction
technique to bypass the curse of dimensionality involved in the nonparametric regression
of the efficient estimation. The dimension reduction assumptions we made are mild in gen-
eral and are applicable in various practical situations. Our approach maintains the model
flexibility as we make no assumption about the regression errors and allow the disease
rate to be unknown. Compared to the semiparametric approach by Lin and Zeng (2009)
that assumes a known or rare disease rate and requires the regression error to be normally
distributed with homoscadistic variance, our approach shows similar performance when
those parametric assumptions holds, and it performs considerably better than Lin and Zeng
(2009) when those parametric assumptions are violated. An interesting direction for future
work would be to further reduce the dimension of the covariates using regularization and to
further improve the estimation efficiency by positing a parametric form, e.g., single-index
model, for the conditional variance of the regression error.
Finally, we derive the locally consistent semiparametric estimators for the secondary
quantile regression model, where only a quantile regression model between covariates
is specified and both the disease rate and the covariate distribution are assumed to be
unknown. Our method involves positing a density function for Y given X that may or
may not be true. The resulting estimator is consistent for an arbitrary posited density and
it is further efficient if the posited model is the truth. Our method outperforms the weighted
estimating equation approach (Wei et al., 2016), the only published approach for secondary
69
quantile regression, in terms of efficiency. Similar to the gene-environment independent
model, the curse of dimensionality emerges in the estimating process, specifically, the
nonparametric regression part. Dimension reduction would be a possible future work.
Another appealing topic is exploring the efficiency gain by further assuming a parametric
form for the regression error as discussed in the secondary mean regression model.
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SKETCH OF TECHNICAL ARGUMENTS FOR SECTION 2
A.1 Identifiability
A1 There exists cx so that when x → cx, m(g, x,β) → ∞ or m(g, x,β) → −∞ for
any g.
A2 There exists g1 and x1, x2 such thatm(g1, x1, β) 6= m(g1, x2, β).
A3 There exists cg so that when g → cg, m(g, x,β) → ∞ or m(g, x,β) → −∞ for
any x.
A4 There exists x1 and g1, g2 such thatm(g1, x1, β) 6= m(g2, x1, β).
Proposition 3. The problem stated in (2.2) is identifiable,
• If condition A1 holds, and at least one of the conditions A3 and A4 holds;
• or if at least one of the conditions A1 and A2 holds, and condition A3 holds.
Remark 4. In practice, a widely used model is the one including main effects and two-way
interaction, i.e., m(g, x,β) = α + β1g + β2x + β3xg. It can be easily verified that if g
and x both have the support on R then this model satisfies conditions A1 and A3 described
above and hence is identifiable.
Remark 5. Proposition 3 applies in the case where at most one of G andX is discrete. In
the case where bothG andX are discrete with levels lG and lX respectively, identifiability
requires lGlX ≥ 2lG + 2lX − 2 as a necessary condition. Additional conditions may be
needed. Although for a specific model with known lG and lX , it can be easy to derive the
sufficient conditions for identifiability, such result is difficult to describe in general.
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Proof of Proposition 3. From Prentice and Pyke (1979), β is identifiable. Thus, we aim
at establishing the identifiability of η1, η2 and α.































2(x)H(0, g, x,β, α
∗).











π∗0/π0 + exp{α +m(g, x,β)}π∗1/π1
1 + exp{α +m(g, x,β)} .
Under condition A1, letting x→ cx, we obtain η∗1(g) = η1(g). Similarly, under condition
A3, letting g → cg, we obtain η∗2(x) = η2(x). This in turn leads to π∗0 = π0, π∗1 = π1.
Finally, these results lead to α∗ = α.
We now prove the result under A1 and A4. Under condition A1 alone, the same deriva-




π∗0/π0 + exp{α +m(g, x,β)}π∗1/π1
1 + exp{α +m(g, x,β)} .
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Thus A4 further implies
π∗0/π0 + exp{α +m(g1, x1,β)}π∗1/π1
1 + exp{α +m(g1, x1,β)} =
π∗0/π0 + exp{α +m(g2, x1,β)}π∗1/π1
1 + exp{α +m(g2, x1,β)} ,
or equivalently, (π∗0/π0 − π∗1/π1)[exp{α +m(g1, x1,β)} − exp{α +m(g2, x1,β)}] = 0.
Hence, π∗d = πd for d = 0, 1. As a result, α
∗ = α and η∗2(x) = η2(x).
The result under A2 and A3 is symmetric to the one under A1 and A4 hence is omitted.
The requirements in A1 and A3 are appropriate in the case where G and X are both
continuous. The requirements in A1 and A4 are suitable in the case where G is discrete
and X is continuous. The requirements in A2 and A3 are suitable in the case where X is
discrete and G is continuous.
A.2 Nuisance Tangent Space Λ and its Orthogonal Complement Λ⊥
The nuisance tangent space Λ is computed in two steps. First, replacing the nuisance











Second, finding the mean squared closure that contains all such Sγ , which is Λ.
For any finite-dimensional parameter γ = (γT1 ,γ
T
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−1∂η2(x,γ2)/∂γ2 − E{η2(x,γ2)−1∂η2(X,γ2)/∂γ2 | D}.





a(g)η1(g)η2(x)H(d, g, x,θ)dµ(x)dµ(g) :
Etrue{a(G)} = 0, a(g) ∈ Rp]





a(x)η1(g)η2(x)H(d, g, x,θ)dµ(x)dµ(g) :
Etrue{a(X)} = 0, a(x) ∈ Rp]
= [a(x)− E{a(X) | d} : ∀a(x) ∈ Rp] .
Then
Λ = Λ1 + Λ2
= [a1(g) + a2(x)− E{a1(G) + a2(X) | d} : ∀a1(g), a2(x) ∈ Rp] .
Define Λ⊥,conj1 = [f(d, g, x) : E(f) = 0, E(f | G) = E{E(f | D) | G}]. Now consider
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f ⊥ Λ1. Then for any a(g)− E{a(G) | d} ∈ Λ1,
0 = E(fT[a(G)− E{a(G) | D}])
= E
[
fTa(G)− fTE{a(G) | D}]
= E
[
fTa(G)− E(fT | D)E{a(G) | D}]
= E
{
fTa(G)− E(fT | D)a(G)}
= E
[
E{fT − E(fT | D) | G}a(G)] .
Hence, E{f − E(f | D) | G} = 0 almost surely. Besides, Λ⊥1 need to be a subspace of
the Hilbert space H, hence E(f) = 0. Thus, we have shown Λ⊥1 ⊂ Λ⊥,conj1 . On the other
hand, for any f ∈ Λ⊥,conj1 ,
E
[
fTa(G)− fTE{a(G) | D}]
= E
{
fTa(G)− E(fT | D)a(G)}
= E
[
E{fT − E(fT | D) | G}a(G)]
= 0,
hence Λ⊥,conj1 ⊂ Λ⊥1 . Thus, we have obtained Λ⊥1 = Λ⊥,conj1 . Similarly, we can prove
Λ⊥2 = [f(d, g, x) : E(f) = 0, E(f | X) = E{E(f | D) | X}]
Hence,
Λ⊥ = [f(d, g, x) : E(f | G) = E{E(f | D) | G}, E(f | X) = E{E(f | D) | X},
E(f) = 0, f ∈ Rp].
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A.3 Uniqueness of a and b up to Constants
To prove that a and b defined in (2.4) - (2.5) are unique up to constant shifts, we
consider the following. If there exists a1, a2,b1,b2 such that
Seff(d, g, x) = S(d, g, x)− a1(g)− b1(x)− E{S(d,G,X) | d}
+E{a1(G) + b1(X) | d}
= S(d, g, x)− a2(g)− b2(x)− E{S(d,G,X) | d}
+E{a2(G) + b2(X) | d},
then
a2(g)− a1(g) = b1(x)− b2(x)− E{a1(G) + b1(X) | d}+ E{a2(G) + b2(X) | d}.
The left-hand side is a function of g while the right-hand side is a function of x and d.
Hence a1(g)− a2(g) is a constant. Similarly, b1(x)− b2(x) is also a constant.
A.4 Equivalent Expression of Equations (2.4) - (2.5) and the Proof Under the Con-
dition E(a) = E(b) = 0
We claim under the mean zero constraint E(a) = E(b) = 0, (2.4) and (2.5) are
equivalent to (A.1), (A.2), and (A.3) below, namely
Sg(g)− E{Sx(X) | g} = a(g) + u0cg(g)− E{E(a | X) | g}
−u0E{cx(X) | g}, (A.1)
Sx(x) = E(a | x) + b(x) + u0cx(x), (A.2)
u0 = E(a+ b | D = 0), (A.3)
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where cx(x) = E[{n0 − nI(D = 0)}/n1 | x], cg(g) = E[{n0 − nI(D = 0)}/n1 | g].
Proof. Suppose a and b are the solution of equations (2.4) and (2.5). Let E(a+ b | D =
0) = u0, E(a+b | D = 1) = u1. Then (A.3) automatically holds. It is easy to verify that
u0n0 + u1n1 = nE(a+ b) = 0. Hence (2.4) and (2.5) become
E(a | x) + b(x) + u0{(n0/n1)fD|X(1, x)− fD|X(0, x)} = Sx(x),
a(g) + E(b | g) + u0{(n0/n1)fD|G(1, g)− fD|G(0, g)} = Sg(g).
Further write
cx(x) = (n0/n1)fD|X(1, x)− fD|X(0, x) = {n0 − nfD|X(0, x)}/n1
= E[{n0 − nI(D = 0)}/n1 | x] = E[{n0/n− I(D = 0)}/(n1/n) | x],
cg(g) = (n0/n1)fD|G(1, g)− fD|G(0, g) = {n0 − nfD|G(0, g)}/n1
= E[{n0 − nI(D = 0)}/n1 | g] = E[{n0/n− I(D = 0)}/(n1/n) | g].
Then
E(a | x) + b(x) + u0cx(x) = Sx(x), (A.4)
a(g) + E(b | g) + u0cg(g) = Sg(g). (A.5)
Note that (A.4) above is exactly (A.2) defined in Section 2.3. Taking conditional expecta-
tion of (A.4) given G = g, we obtain
E{E(a | X) | g}+ E(b | g) + u0E{cx(X) | g} = E{Sx(X) | g}.
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Subtracting the above from (A.5), we obtain (A.1), namely
a(g) + u0cg(g)− E{E(a | X) | g} − u0E{cx(X) | g} = Sg(g)− E{Sx(X) | g}.
From the above derivation, it is clear that any mean zero functions a(g),b(x) that solve
(2.4) and (2.5) also satisfy (A.1), (A.2), and (A.3). We now prove the other way around,
that is any mean zero functions a(g),b(x) that satisfy (A.1), (A.2), and (A.3) also satisfy
(2.4) and (2.5).
Taking the expectation of (A.2) conditionally on G = g and adding the resulting equa-
tion to (A.1), we obtain exactly (A.5). Hence equations (A.2), (A.1) lead to equations
(A.2), (A.5).
For preparation, note also that cg(g) = (n0/n1)fD|G(1, g) − fD|G(0, g). Hence under
(A.3) and the condition n1E(a + b | D = 1) + n0E(a + b | D = 0) = nE(a + b) = 0,
we can further write
u0cg(g) = E(a+ b | D = 0){(n0/n1)fD|G(1, g)− fD|G(0, g)}
= E(a+ b | D = 0)(n0/n1)fD|G(1, g)− E(a+ b | D = 0)fD|G(0, g)
= −E(a+ b | D = 1)fD|G(1, g)− E(a+ b | D = 0)fD|G(0, g)
= −E{E(a+ b | D) | g}.
Similarly, u0cx(x) = −E{E(a+ b | D) | x}. From (A.2), we obtain
Sx(x) = E(a | x) + b(x) + u0cx(x) = E(a | x) + b(x)− E{E(a+ b | D) | x},
which is exactly (2.4). Similarly, from (A.5), we obtain (2.5).
Equation (A.1) allows us to solve for a(g) as a function of u0 and other known quan-
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tities, say a(g) = Fa(g,u0) − E{Fa(G,u0)}, where Fa is a function that solves (A.1)
which does not need to have mean 0. Then we can solve b(·) from (A.2) as a function of
u0 to obtain
b(x) = Sx(x)− u0cx(x)− E{Fa(G,u0) | x}+ E{Fa(G,u0)}.
Now
u0 = E{a(G) + b(X) | D = 0}
= E[Fa(G,u0) + Sx(X)− u0cx(X)− E{Fa(G,u0) | X} | D = 0],
which allows us to solve for u0. Having obtained u0, we can then solve for all other quan-
tities easily. Unfortunately, the integral equation (A.1) does not have an explicit solution.
We propose an approximation to its solution in the spirit of Tsiatis and Ma (2004), which
is provided in Appendix A.5, by discretizing X if X is continuous.
The efficient score Seff , especially the procedure of solving for a and b, contains sev-
eral expectations conditional on D, G, or X . To get estimations of these conditional
expectations, we need density estimators of the nuisance parameter η = (η1, η2). If the
disease rate π1 or the non-disease rate π0 = 1− π1 is known, then η can be approximated
by
η̂1 = π0f̂G|D=0 + (1− π0)f̂G|D=1, η̂2 = π0f̂X|D=0 + (1− π0)f̂X|D=1,
where f̂G|D=d and f̂X|D=d are the nonparametric estimators of the conditional density/mass
function fG|D=d and fX|D=d respectively for d = 0, 1. Of course, in practice, π0 is typically
unknown. However, we can get an estimate of π0 through (2.3).
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A.5 Solving the Integral Equation (A.1)
Define Z = S − E(S | D) − u0{n0 − nI(D = 0)}/n1. An equivalent expression of
(A.1) is
a(G)− E[E{a(G) | X} | G] = E(Z | G)− E{E(Z | X) | G}. (A.6)
For fixed u0, all the quantities in Z are known or have explicit form except E(S | D).
With the weighted kernel density η̂1, η̂2, estimated non-disease rate π̂0 and disease rate π̂1,
we can estimate it by Ê(S | D = d) = π̂−1d
∫
S(d, g, x)η̂1(g), η̂2(x)dµ(g)dµ(x).
A.5.1 Discrete G with finite number of levels
Assume G is discrete with mass at mg points g1, · · · , gmg . We computed each term in
(A.6) under the weighted nonparametric densities η̂1, η̂2.


















d=0 nd/(nπd)Z(d, gj, x)H(d, gj, x)η̂1(gj)∑mg
j=1 κ(gj, x)η̂1(gj)
,




















Consequently, the integral equation (A.6) reduces to the linear equations
(I −B)AT = CT,
where A is the (p + 1) × mg matrix {a(g1), · · · , a(gmg)}, corresponding to the solution
of the integral equation, I is an mg ×mg identity matrix, B is an mg ×mg matrix whose









and C is a (p+ 1)×mg matrix whose kth column is
Ê{Z(D,G,X) | gk} − Ê[Ê{Z(D,G,X) | X} | gk]
defined in (A.7) and (A.8).
After obtaining a, we set













Then we compute u0 = Ê(a+ b | D = 0), where




H(0, gj, x)η̂2(x)dµ(x)∫ ∑mg
j=1H(0, gj, x)η̂1(gj)η̂2(x)dµ(x)
,




j=1H(0, gj, x)η̂1(gj)η̂2(x)∫ ∑mg
j=1H(0, gj, x)η̂1(gj)η̂2(x)dµ(x)
dµ(x).
A.5.2 Continuous G or Discrete G with Infinite Number of Levels
When G is a continuous variable, we discretize it at a finite number of equally dis-




Similarly, when G is discrete with infinite number of levels, we simply choose a sufficient
number of points from its support to get an overall probability close to 1.
Then the sequential procedures are exactly the same as that described in the case where
G is discrete with finite number of levels.
A.6 Proof of Theorem 2
We divided the n observations randomly into two data sets with sample sizes N1 =
n − n1−δ and N2 = n1−δ, where δ > 0 is a small positive number. The first data set with
size N1 is used to form the estimating equation while the second data set with size N2 is
used for weighted nonparametric density estimation.
Before proving Theorem 2, we first establish some preliminary results in Lemmas 1-4.
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Lemma 1. As an equation to solve for π,
π =
∫
H(0, g, x){πfG|D=0(g) + (1− π)fG|D=1(g)}
×{πfX|D=0(x) + (1− π)fX|D=1(x)}dµ(g)dµ(x) (A.9)
has at most two roots. Only one root lies between 0 and 1, and it is the true non-disease
rate π0. Here fG|D=d(g) is the density/mass function of G in the control (d=0) and case
(d = 1) subpopulations respectively, and fX|D=d(x) is similarly defined.
Proof. It is obvious that π0 satisfies (A.9) hence is a solution for the quadratic equation
π =
∫
H(0, g, x){πfG|D=0(g) + (1− π)fG|D=1(g)}
×{πfX|D=0(x) + (1− π)fX|D=1(x)}dµ(g)dµ(x)















(a− b+ c)π2 + (b− 2c− 1)π + c = 0. (A.10)
We now show (A.10) has only one root in (0, 1). Obviously, if a − b + c = 0, (A.10) is a
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linear equation hence it only has one root, which is shown to be π0. If a− b+ c 6= 0, as a
quadratic function, its delta value is (b−2c−1)2−4(a−b+c)c = (b−1)2+4c(1−a) > 0, as
a, b, c are all positive, and a =
∫
H(0, g, x)fG|D=0(g)fX|D=0(x)dµ(g)dµ(x) < 1. Hence
(A.10) has two roots. One of the two root is π0 ∈ (0, 1). Now (A.10) evaluated at π = 0
and π = 1 are respectively c > 0 and a− 1 < 0, hence (A.10) has a second root either in
(∞, 0) or in (1,∞). This proves that π0 is the unique root in (0, 1).
Lemma 2. AssumingG is discrete, then for fixed g and d = 0, 1. |f̂G|D=d(g)−fG|D=d(g)| =
Op(1/
√
N2), where f̂G|D=d(g) is the empirical estimator of fG|D=d(g).
Proof. For g on the support of fG|D=d(g), we have
f̂G|D=d(g) =
∑N2
i=1I(Gi = g,Di = d)/
∑N2
i=1I(Di = d).
Define p1 = pr(G = g,D = d), p2 = pr(D = d), then we have E{N−12
∑N2
i=1 I(Gi =
g,Di = d)} = p1, var{N−12
∑N2
i=1 I(Gi = g,Di = d)} = p1(1 − p1)/N2. Similarly,
E{N−12
∑N2
i=1 I(Di = d)} = p2, var{N−12
∑N2
i=1 I(Di = d)} = p2(1− p2)/N2.





i=1 I(Gi = g,Di = d) − p1}




P→ p2, and henceN1/22 {f̂G|D=d(g)−fG|D=d(g)} D→ Normal{0, p1(1−p1)/p22} following
Slutsky’s theorem. Thus, Lemma 2 is shown.
Lemma 3. As an equation to solve for π,
π =
∫
H(0, g, x){πf̂G|D=0(g) + (1− π)f̂G|D=1(g)}
×{πf̂X|D=0(x) + (1− π)f̂X|D=1(x)}dµ(g)dµ(x)
has at most two roots. Here f̂G|D=d(g) and f̂X|D=d(x) are respectively the nonparametric
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estimates of fG|D=d(g) and fX|D=d(x). Let π̂0 denote the solution that is closest to π0, then
under the regularity conditions defined in Section 2.4, π̂0 = π0 +Op{h2 + (N2h)−1/2}.
Proof. We will only prove the result for discrete G and continuous X . Because of the
symmetry, the result for continuous G and discrete X automatically holds. The proof for
continuous G and X is similar. We rewrite the equation of π as
π =
∫
H(0, g, x){πf̂G|D=0(g) + (1− π)f̂G|D=1(g)}
×{πf̂X|D=0(x) + (1− π)f̂X|D=1(x)}dµ(g)dµ(x)
=
∫
H(0, g, x){πfG|D=0(g) + (1− π)fG|D=1(g)}
×{πfX|D=0(x) + (1− π)fX|D=1(x)}dµ(g)dµ(x)
+
∫
H(0, g, x)[π{f̂G|D=0(g)− fG|D=0(g)}+ (1− π){f̂G|D=1(g)− fG|D=1(g)}]
×{πfX|D=0(x) + (1− π)fX|D=1(x)}dµ(g)dµ(x)
+
∫
H(0, g, x){πfG|D=0(g) + (1− π)fG|D=1(g)}
×[π{f̂X|D=0(x)− fX|D=0(x)}+ (1− π){f̂X|D=1(x)− fX|D=1(x)}]dµ(g)dµ(x)
+
∫
H(0, g, x)[π{f̂G|D=0(g)− fG|D=0(g)}+ (1− π){f̂G|D=1(g)− fG|D=1(g)}]
×[π{f̂X|D=0(x)− fX|D=0(x)}+ (1− π){f̂X|D=1(x)− fX|D=1(x)}]dµ(g)dµ(x).
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Now we examine the last three integrals in the above equation one by one. First,
∣∣∣∣∫ H(0, g, x)[π{f̂G|D=0(g)− fG|D=0(g)}+ (1− π){f̂G|D=1(g)− fG|D=1(g)}]
×{πfX|D=0(x) + (1− π)fX|D=1(x)}dµ(g)dµ(x)
∣∣
≤
∫ ∣∣∣π{f̂G|D=0(g)− fG|D=0(g)}+ (1− π){f̂G|D=1(g)− fG|D=1(g)}∣∣∣
×{πfX|D=0(x) + (1− π)fX|D=1(x)}dµ(g)dµ(x)
=




where the last equality is a direct result of Lemma 2. Similarly,
∣∣∣∣∫ H(0, g, x){πfG|D=0(g) + (1− π)fG|D=1(g)}
×[π{f̂X|D=0(x)− fX|D=0(x)}+ (1− π){f̂X|D=1(x)− fX|D=1(x)}]dµ(g)dµ(x)
∣∣∣
≤
∫ ∣∣∣π{f̂X|D=0(x)− fX|D=0(x)}+ (1− π){f̂X|D=1(x)− fX|D=1(x)}∣∣∣ dµ(x)
= Op{h2 + (N2h)−1/2},
where the last equality is the direct result of the nonparametric density estimation property.
Following the same procedure, we have
∣∣∣∣∫ H(0, g, x)[π{f̂G|D=0(g)− fG|D=0(g)}+ (1− π){f̂G|D=1(g)− fG|D=1(g)}]
×[π{f̂X|D=0(x)− fX|D=0(x)}+ (1− π){f̂X|D=1(x)− fX|D=1(x)}]dµ(g)dµ(x)
∣∣∣
≤
∫ ∣∣∣π{f̂G|D=0(g)− fG|D=0(g)}+ (1− π){f̂G|D=1(g)− fG|D=1(g)}∣∣∣ dµ(g)
×










H(0, g, x){πfG|D=0(g) + (1− π)fG|D=1(g)}
×{πfX|D=0(x) + (1− π)fX|D=1(x)}dµ(g)dµ(x) +Op(h2) +Op(1/
√
N2h).
Lemma 1 then immediately leads to the conclusion.
Remark 6. Lemma 3 can be further generalized to the case where the discrete covari-
ates can have infinitely many levels and the continuous covariates can have noncompact
support, as long as the tails of these distributions are sufficiently thin. The proofs will be
more complicated, involving splitting the domain of the covariates into two parts, where
the treatment in one part controls the error rate via the nonparametric estimation rate,
and the treatment in the other part controls error rate via the tail behavior itself. To avoid
extremely technicality, we skip the detailed proofs.
The above results directly lead to Lemma 4.
Lemma 4. The weighted nonparametric density estimates η̂1(·), η̂2(·) defined in Algorithm
1 Step 4 have at least the usual nonparametric convergence rate. Specifically,
η̂1(·)− η1(·) = Op(h2) +Op(1/
√
nh),
η̂2(·)− η2(·) = Op(h2) +Op(1/
√
nh).
Now we are ready to prove Theorem 2, the main theoretic result of our work.
Proof of Theorem 2.
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The efficient score is
Seff{d, g, x,θ,η(·)}
= S(d, g, x,θ)− a{g,θ,η(·)} − b{x,θ,η(·)} − Eη(·){S(d,G,X,θ) | d}
+Eη(·)[a{G,θ,η(·)}+ b{X,θ,η(·)} | d],
where
Eη{a(G,θ,η) | x}+ b(x,θ,η)− E{E(a+ b | D) | x}
= Eη(S | x)− Eη{E(S | D) | x},
a(g,θ,η) + Eη{b(X,θ,η) | g} − Eη{Eη(a+ b | D) | g}
= Eη(S | g)− Eη{Eη(S | D) | g}.
Here η(·) = {η1(·), η2(·)} stands for the nuisance parameter, which is free of θ. The nota-
tion a(g,θ,η),b(x, θ,η) and Eη(·) emphasize that they are calculated under the nuisance
parameter η.
When we adopt the weighted nonparametric estimation for the density ofG andX , the
estimated efficient score is Seff{d, g, x,θ, η̂(·,θ)}, where η̂(·,θ) = {η̂1(·,θ), η̂2(·,θ)}T.
Here η̂1(·,θ) and η̂2(·,θ) are defined in Algorithm 1. Note that η̂(·,θ) is computed using
a subset of the data with N2 observations, while the final estimating equation is computed
using the rest of the data with N1 = n−N2 observations.
Let θ̂ denote the solution of
0 =
∑N1






































1 (θ̂ − θ) (A.11)
Here θ∗ is on the line connecting θ̂ and θ.






































i=1Seff{Di, Gi, Xi,θ,η(·)}+ op(1),
where η∗ is an intermediate value between η(·) and η̂(·,θ), and the derivative with respect
to η is the Gâteaux derivative. Here in the last equality, the last term is of order op(1)
because of the convergence rate of η̂1, η̂2 in Lemma 4 and the regularity conditionN1h
8 →
0 and N1h


















due to the central limit theorem. The above expectation vanishes because the efficient score
lies in Λ⊥ and any directional derivative with respect to any component in the nuisance












Seff{Di, Gi, Xi,θ,η(·,θ)}+ op(1),


















1 (θ̂ − θ),
and the results follow.
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APPENDIX B
SKETCH OF TECHNICAL ARGUMENTS FOR SECTION 3
B.1 Dimension Reduction Model for ǫµs
The dimension reduction assumption (3.9) on ǫµs is more complicated than (3.8) or
(3.10), and requires careful attention.






 {d−H(1,X, Y,α)} (1,XT, Y )T
−{η∗2(ǫ,X)−1∂η∗2(ǫ,X)/∂ǫ} × {∂m(X,β)/∂β}
 ,
where y = m(x,β) + ǫ. Here η∗2 is the posited conditional density of ǫ given X, not
necessarily the true model. Let w(d,x, y;α) = d−H(1,X, Y,α), so that
µs = E(S
∗ | ǫ,X) =




r(x, y;α) = E{w(D,X, Y ) | X, Y }
=
∑1
d=0ndH(d,X, Y )w(d,X, Y )κ(X, Y )/(nπd),
= n−1 (n1/π1 − n0/π0)H(0,X, Y )H(1,X, Y )κ(X, Y );







Etrue{ǫµs(X, Y ) | X} =

Etrue{ǫr(X, Y ;α) | X}(1,XT)T
Etrue{ǫr(X, Y ;α)m(X,β) + ǫ2r(X, Y ;α) | X}
−Etrue {ǫη∗2(ǫ,X)−1∂η∗2(ǫ,X)/∂ǫ | X} {∂m(X,β)/∂β}
 .
We assume the following models hold.
Etrue{ǫr(X, Y ;α) | X} = ζ21(ZTβγ21); (B.1)









where Z = {XT,m(X,β)}T when m is nonlinear while Z = X when m is linear. For
identifiability, the lower square blocks of γ2j, j = 1, 2, 3 are fixed to be identity.






i=1I{Di = d}ǫir(Xi, Yi;α)Kh(ZTi γ21 − ZTγ21)∑1
d=0π̂d/nd
∑N







i=1I{Di = d}ǫ2i r(Xi, Yi;α)Kh(ZTi γ22 − ZTγ22)∑1
d=0π̂d/nd
∑N
















i γ23 − ZTγ23)∑1
d=0π̂d/nd
∑N
i=1I{Di = d}Kh(ZTi γ23 − ZTγ23)
. (B.6)










ǫj(Xj , Yj,β)r(Xj , Yj ,α)− ζ̂21(ZTj γ21)
}{
Z∗β,j − Êπ̂true(Z∗β,j | Z∗β,jγ)
}
.
Similar results work for γ22,−1 and γ23,−1. Denote the resulting estimators by γ̂2j,−1 and
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let γ̂2j = (γ̂
T
2j,−1, 1)
T for j = 1, 2, 3. Then Etrue{ǫµs(X, Y ) | X} can be estimated by










In all of our simulations, m(X,β) = β0 + X
Tβ1. In addition, the posited model is
standard normal, and simplifications result. Thus, ∂{logη∗2(ǫ,X)}/∂ǫ is simply−ǫ. In our
simulations, we further take γ21 = γ22 = γ23 = γ2 for computational and programming
simplicity. As a result, we have that
S∗ =
[{d−H(1,X, Y,α)} (1,XT, Y ), ǫ(1,XT)]T ;
µs = E{S∗ | ǫ,X} = {r(X, Y ;α)(1,XT, Y ), ǫ(1,XT)}T.
Then
Etrue{ǫµs(X, Y ) | X} =

Etrue{ǫr(X, Y ;α) | X}(1,XT)T
Etrue{ǫr(X, Y ;α) | X}m(X,β) + Etrue{ǫ2r(X, Y ;α) | X}
Etrue{ǫ2 | X}(1,XT)T
 .







i=1I{Di = d}ǫir(Xi, Yi;α)Kh(ZTi γ2 − ZTγ2)∑1
d=0π̂d/nd
∑N







i=1I{Di = d}ǫ2i r(Xi, Yi;α)Kh(ZTi γ2 − ZTγ2)∑1
d=0π̂d/nd
∑N







i=1I{Di = d}ǫ2iKh(ZTi γ2 − ZTγ2)∑1
d=0π̂d/nd
∑N
i=1I{Di = d}Kh(ZTi γ2 − ZTγ2)
,
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where again the lower square block of γ2 is fixed to be identity. The consistent estimator









{ǫj(Xj , Yj,β)r(Xj , Yj ,α)− ζ̂21(ZTj γ2)}




Z∗β,j − Êπ̂true(Z∗β,j | Z∗β,jγ)
}
.
Denote the resulting estimators γ̂2,−1 and let γ̂2 = (γ̂
T
2,−1, 1)
T. ThenEtrue{ǫµs(X, Y ) |
X} can be estimated by










B.2 Details for the Algorithm in Section 3.4
B.2.1 Algorithm Using Different Indices
1. Posit a model for η2(ǫ,x) which has mean zero. Under this posited model, calculate
S∗ from (3.6).
2. Solve π̂0(α) =
∑n
i=1H(0,Xi, Yi,α)[n0H(0,Xi, Yi,α)/π̂0(α) + n1H(1,Xi, Yi,
α)/{1− π̂0(α)}]−1, and set π̂1(α) = 1− π̂0(α).
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3. Obtain
κ̂i = κ̂(Xi, Yi,α) = [
∑
dndH(d,Xi, Yi,α)/{nπ̂d(α)}]−1
f̂0i = f̂D|X,Y (0,Xi, Yi,α) = n0H(0,Xi, Yi,α)κ̂i/{nπ̂0(α)}
f̂1i = f̂D|X,Y (1,Xi, Yi,α) = n1H(1,Xi, Yi,α)κ̂i/{nπ̂1(α)}
µ̂si = Ê(S
∗





















i=1 {S∗(1,Xi, Yi,α)− µ̂si} f̂1i/
∑N
i=1f̂1i.
4. Estimate Etrue{ǫ2κ̂(X, Y ) | X} using nonparametric regression under the dimen-









i 6=j I(Di = d)ǫ
2











for j = 1, · · · , n. Here ǫi(Xi, Yi,β) = Yi − m(Xi,β). Zβ,i = X if m(·) is
linear inX; Z = {XTi ,m(Xi,β)}T, otherwise.






j=1I(Dj = d){ǫ2j(Xj, Yj,β)κ̂(Xj, Yj,α)
−Êπ̂1 (Xj,γ1,θ)}{Z∗β,j − Êπ̂true(Z∗β,j | ZTβ,jγ1)},
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i (Xi, Yi,β)κ̂(Xi, Yi,α)Kh(Z
T







β,iγ̂1 − ZTβ γ̂1)
.
5. Estimate Etrue{ǫµ̂s(X, Y ) | X} using nonparametric regression under the dimen-
sion reduction model assumption (3.9). Because Etrue{ǫµ̂s(X, Y ) | X} actually
consists of three separate dimension reduction models, its estimation is slightly
complex. We give the estimation details in Appendix B.1 and denote the resulting
estimator by Êtrue {ǫ(X, Y,β)µ̂s(X, Y,α) | X}.
6. EstimateEtrue{ǫf̂0(X, Y ) | X} using nonparametric regression under the dimension




















for j = 1, · · · , n.
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j=1I(Dj = d){ǫj(Xj, Yj ,β)f̂0(Xj, Yj,α)






































i=1I(Di = d)ǫi(Xi, Yi,β)f̂0(Xi, Yi,α)Kh(Z
T







β,iγ̂3 − ZTβ γ̂3)
.
7. (a) Form t̂1(X) = {Êtrue(ǫ2κ̂(X, Y )|X)}−1, t̂2(X) = Êtrue(ǫµ̂s | X)− (ĉ0/b̂0)
× Êtrue(ǫf̂0 | X) and t̂3(x) = −b̂−10 Êtrue(ǫf̂0 | x).










i=1 f̂0i and û0 =
(
1− Ê [ǫt1(x)t3(x)κ(x, y) | D = 0]
)−1
× Ê [ǫt1(x)t2(x)κ(x, y) | D = 0].
(c) Form û1 = −(n0/n1)û0, v̂0 = (π̂1/b̂0)(û0+ ĉ0) and v̂1 = −(π̂0/b̂0)(û0+ ĉ0).
(d) Form â(x) = t̂1(x){t̂2(x) + t̂3(x)û0).
(e) Form ĝi = µ̂si − ǫiâ(Xi)κ̂i − v̂0f̂0i − v̂1f̂1i.
(f) Form v̂Di = (1−Di)v̂0 +Div1.
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(g) Form Ŝ∗eff(Di,Xi, Yi) = S
∗
i − ĝi− v̂Di and solve the corresponding estimating
equation.
B.2.2 Algorithm Using A Common Index

































I{Di = d}Kh(ZTβ,iγ − ZTβ,jγ)
.
(B.8)
Construct Êπ̂2 (Xj,γ2,θ) = Êtrue{ǫjµ̂s(Xj, Yj) | Xj} for j = 1, · · · , n, with the
method given in Appendix B.1.










ǫ2j(Xj, Yj,β)κ̂(Xj, Yj,α)− Êπ̂1 (Xj,γ,θ)
+1Tdim(θ)
{
ǫj(Xj, Yj,β)µ̂s(Xj, Yj,α)− Êπ̂2 (Xj,γ,θ)
}

















































i=1I{Di = d}Kh(ZTβ,iγ̂ − ZTβ γ̂)
;





























i=1I{Di = d}Kh(ZTβ,iγ̂ − ZTβ γ̂)
.
B.3 Regularity Conditions
Let ℓ be the dimensionality of the kernel regressions in our method after dimension
reduction. In our simulations and example, we took ℓ = 1. The set of regularity conditions
required by Theorem 3 is listed below.
C1. The univariate kernel function is a function that integrates to 1 and has support
(−1, 1) and order r, i.e., ∫ K(u)utdu = 0 if 1 ≤ t < r and ∫ K(u)urdu 6= 0. The
ℓ-dimensional kernel function, still represented with K, is a product of ℓ univariate
kernel functions, that is, K(u) =
∏ℓ
i=1K(ui) for a ℓ-dimensional u.
C2. Let ξtrue
i,β˜
be the true population density of ZT
β˜
γi for i = 1, 2, 3 and β˜ in a local
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neighborhood of β. Assume that ξtrue
i,β˜
’s are bounded away from 0 and they all have
third order bounded and continuous derivatives.
C3. At any fixed α˜ in a local neighborhood of α, ζ1(·, α˜), ζ2(·, α˜) and ζ3(·, α˜) are
functions of · with second order bounded and continuous derivatives.
C4. Etrue{ǫ4(X, Y, β˜)κ2(X, Y, α˜)|X}, Etrue{ǫ2(X, Y, β˜)µs(X, Y, α˜)
⊗
2|X} and


















































































have (r+1)th order bounded and continuous

























































ǫf0(X, Y, α˜)Zβ˜ | ZTβ˜γ3
}
have (r+1)th order bounded and contin-




































































ǫ2f 20 (X, Y, α˜){Zβ˜ − Z′β˜}{Zβ˜ − Z′β˜}T | ZTβ˜γ3,X
]
all have bounded en-
tries for any θ˜ in a local neighborhood of θ, where Z′
β˜
is an independent and identi-




C8. πd(α˜)/(nd/n) are bounded for d = 0, 1.
C9. πd(α˜)/πd(α) are bounded for d = 0, 1.
C10. The bandwidth h = n−τ where 1/(2ℓ) > τ > 1/(4r). This includes the optimal
bandwidth h = O(n−1/(2r+ℓ)) as long as we choose a kernel of order 2r > ℓ.
C11. There exists a positive constant C such that limn→∞ n0/n1 = C <∞.
Conditions C1 and C10 are standard requirements on an rth order kernel function and the
bandwidth, which ensure the resulting nonparametric regression estimators to be consis-
tent (Ma and Zhu, 2013).
B.4 Proof of Proposition 1
We provide a detailed proof that the first dimension reduction model (3.8) satisfies
Proposition 1. Proving that the other two dimension reduction models (3.9) and (3.10)
also satisfy Proposition 1 is similar.
In (3.8), κ(x, y,α) is a function of the weighted sum ofH(d,x, y) with d = 0, 1. As a
result,
κ(x, y,α) = h{xTα1 +m(x,β)α2 + ǫα2}
= h[{xT,m(x,β)}(αT1 , α2)T + ǫα2],
where h(·) is a differentiable function.
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For ǫ = Q(XTω, ǫ∗), where Q(·) is an arbitrary function,
E{ǫ2κ(X, Y,α) | X}
= E(ǫ2h[{XT,m(X,β)}(αT1 , α2)T + ǫα2] | X)
= E{Q(XTω, ǫ∗)2h[{XT,m(X,β)}(αT1 , α2)T +Q(XTω, ǫ∗)α2] | X}
= ζ1(X




where ζ1(·) is a smooth function, Zβ = X and γ1 = (ω,α1 + α2β) is a p × 2 matrix if
m(·) is linear in X; otherwise, Zβ = {XT,m(X,β)}T and γ1 = {(ωT, 0)T, (αT1 , α2)T}
is a (p+ 1)× 2 matrix.
B.5 Background and Technical Results
B.5.1 Introduction
Following Ma and Carroll (2016), we divide the n observations randomly into three
sets, where the first set contains N1 = n − n1−δ − n1−2δ observations, the second set
contains N2 = n
1−δ observations and the third set contains N3 = n
1−2δ observations,
where δ is a small positive number. For convenience of proof, we require the disease
proportion in the third data set to be the same as the whole data set. That is, N30/N31 =
n0/n1, where N30 and N31 are the numbers of controls and cases in the third set of data,
respectively. We form and solve the estimating equation (3.5) using data in the first set
while calculating all the estimated quantities described in Appendix B.2 steps 1-3 using
data in the second set and the other estimated quantities defined in Appendix B.2 steps 4-6
using the data in the third set.
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B.5.2 Lemmas
Before proving Theorem 3, we first state several lemmas, which ensure the quantities
defined in Appendix B.2 steps 4-6 have the desired orders of bias and mean square error,
i.e., the same as that of the usual nonparametric estimators.
From (3.12), we can easily show that
Lemma 5. For some σ2πd(α˜) < ∞,
√
N2{π̂d(α˜) − πd(α˜)} d→ Normal(0, σ2πd(α˜)),as n →
∞.
We now analyze the property of our estimators defined in Appendix B.2 steps 4-6. For
notational brevity, we only focus on the first conditional expectation Etrue{ǫ2κ(X, Y )|X}.
The other two conditional expectations have similar properties. We split the analysis into
three parts: i) analyze the properties of Êπ̂1 (Xj,γ1, θ˜); ii) analyze the properties of γ̂1(θ˜)
for θ˜ near θ; iii) show that Êtrue{ǫ2(X, Y, β˜)κ̂(X, Y, α˜) | X} has desired bias order and
standard deviation order.
For the first part of the analysis, we establish the following lemma.
Lemma 6. Under the regularity conditions C1-C10,
Êπ̂1 (Xj,γ1, θ˜) = Ê1(Xj,γ1, θ˜) +Op(n
−1/2
2 )























































Proof. Denote the numerator and denominator of Êπ̂1 (Xj,γ1, θ˜) by qnum and qden respec-
tively. We can replace π̂d(α˜) in qnum and qden with πd(α˜) without changing the error order
due to the data partition scheme we use. That is,























i (Xi, Yi, β˜)





















i (Xi, Yi, β˜)κ(Xi, Yi, α˜)
×Kh(ZTβ˜,iγ1 − ZTβ˜,jγ1).
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With further calculations, this means that
qnum = Op(N
−1/2






















i (Xi, Yi, β˜)










i (Xi, Yi, β˜)
×κ(Xi, Yi, α˜)Kh(ZTβ˜,iγ1 − ZTβ˜,jγ1)









i (Xi, Yi, β˜)κ(Xi, Yi, α˜)


























ǫ2(X, Y, β˜)κ(X, Y, α˜)Kh(Z
T
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ǫ2(X, Y, β˜)κ(X, Y, α˜)Kh(Z
T
β˜

















































Here we used the regularity conditions C1-C2, C5, C8-C10.
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In addition, with the regularity conditions C1-C4 and C8-C10, we have
var (qnum | Xj)





I(D = d)ǫ2(X, Y, β˜)κ(X, Y, α˜)






















I(D = d)ǫ2(X, Y, β˜)κ(X, Y, α˜)
























































I(D = d)ǫ4(X, Y, β˜)κ2(X, Y, α˜)K2h(Z
T
β˜








ǫ4(X, Y, β˜)κ2(X, Y, α˜)K2h(Z
T
β˜




ǫ4(X, Y, β˜)κ2(X, Y, α˜)K2h(Z
T
β˜
























where C,C ′ are constants.














































































































































We skip the proof of the Lemma 3 here since it is similar to the proof of Lemma 2.
Next, we establish the root-N3 consistency of γ̂j,−1 for j = 1, · · · , 3.
Lemma 8. Under the regularity conditions C1-C10,
√
N3{γ̂1,−1(θ̂)− γ1,−1} → Normal(0,Σγ1,−1),√
N3{γ̂2,−1(θ̂)− γ2,−1} → Normal(0,Σγ2,−1),√
N3{γ̂3,−1(θ̂)− γ3,−1} → Normal(0,Σγ3,−1),
when n→∞. Here Σγ1,−1 , Σγ2,−1 and Σγ3,−1 are positive definite matrices.
Proof. Here we only provide the proof of the root-N3 consistency of γ̂1,−1 below. Similar







































− Êtrue(Z∗β˜,j | ZTβ˜,jγ1)
}
+Op{(N3/N2)1/2},














ǫ2j(Xj, Yj, β˜)κ(Xj, Yj, α˜)− E1(Xj,γ1, θ˜)































































I(Dj = d) (B.9)
×
{



























(Xj ,γ1, θ˜)− Êtrue(Z∗β˜,j | ZTβ˜,jγ1)
}
+op(1).














(Xj ,γ1, θ˜)− Êtrue(Z∗β˜,j | ZTβ˜,jγ1)
}∥∥∥
=
∣∣∣∣N1/23 {Op(hr) +Op (N−1/23 h−ℓ/2)}2∣∣∣∣ = op(1).
By applying Lemma A1 in Ma and Zhu (2012), we obtain that the second and third
terms in (B.9) are of order Op{hr + N1/23 h2r + log2N3/
√
N3h2ℓ} = op(1). Hence, the































×{ǫ2j(Xj, Yj ,β)κ(Xj , Yj,α)− E1(Xj,γ1,θ)}{Z∗j − EZ∗(Xj,γ1,θ)}]
= Etrue
[{












The last equality is because of the single index model assumption (3.8). In practical oper-
ation, we will replace θ˜ by θ̂, the solution of the estimating equation defined in (3.13). As
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long as θ̂ → θ in probability, the above expectation approaches 0.
Hence, we have that
√
N3{γ̂1,−1(θ̂)− γ1,−1} → Normal(0,Σγ1,−1)
when n→∞, where Σγ1,−1 is a positive definite matrix.
We now analyze Êtrue{ǫ2(X, Y, β̂)κ̂(X, Y, α̂) | X}. We will show that it has bias
order Op(h







as given in the following lemma.
Lemma 9. Under the regularity conditions C1-C10,































Proof. Similar to the proof of Lemma 6, we have that







i=1 I(Di = d)ǫ
2












i=1 I(Di = d)ǫ
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Here γ∗1 is on the interval connecting γ̂1(θ̂) and γ1. In the second equality above, we used



















































































































B.6 Proof of Theorem 3
Through the analyses in the lemmas, we proved that all the estimated quantities defined
in Appendix B.2.1 have desired bias order and standard deviation orders. Specifically,
the difference between the quantities with hat and without hat either have mean zero,
standard deviation Op(n
−1/2
2 ) = Op(N
−1/2
3 ) or have bias Op(h




































































































SKETCH OF TECHNICAL ARGUMENTS FOR SECTION 4
C.1 Identifiability
We prove Proposition 2 through contradition. Assume the problem is not identifiable.
Then there must exist αc,α1, α2,βτ , η1, η2 and α˜c, α˜1, α˜2, β˜τ , η˜1, η˜2 such that
π−1d η1(x)η2(y − βτ,c − xTβτ ,x)
exp{d(αc +αT1 x+ α2y)}
1 + exp(αc +αT1 x+ α2y)
= π˜−1d η˜1(x)η˜2(y − β˜τ,c − xTβ˜τ ,x)
exp{d(α˜c + α˜T1 x+ α˜2y)}
1 + exp(α˜c + α˜T1 x+ α˜2y)
, (C.1)
for all (x, y, d), where
πd =
∫
η1(x)η2(y − βτ,c − xTβτ ,x) exp{d(αc +α
T
1 x+ α2y)}




η˜1(x)η˜2(y − β˜τ,c − xTβ˜τ ,x) exp{d(α˜c + α˜
T
1 x+ α˜2y)}
1 + exp(α˜c + α˜T1 x+ α˜2y)
dµ(x)dµ(y).
Take the ratio of the expression (C.1) at d = 1 and d = 0 respectively, we obtain that









This yields that αc − α˜c + xT(α1 − α˜1) + y(α2 − α˜2) is a constant. Hence, we have
α1 = α˜1 and α2 = α˜2. Furthermore, exp(αc)π0/π1 = exp(α˜c)π˜0/π˜1 and
1
π0
η1(x)η2(y − βτ,c − xTβτ ,x)




η˜1(x)η˜2(y − β˜τ,c − xTβ˜τ ,x)
1 + exp(α˜c + xTα1 + yα2)
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for all (x, y). This gives




1 + exp(α˜c + x
Tα1 + yα2)
1 + exp(αc + xTα1 + yα2)
η1(x)η2(y − βτ,c − xTβτ ,x) (C.2)
Now consider the case that αc = α˜c, then πd = π˜d for d = 0, 1 and (C.2) leads to
η˜1(x)η˜2(y − β˜τ,c − xTβ˜τ ,x) = η1(x)η2(y − βτ,c − xTβτ ,x).
Integrating the above equation with respect to y, we obtain η1(x) = η˜1(x). This subse-




η2(y − βτ,c − xTβτ ,x)dµ(y) =
∫ βτ,c+xTβτ
−∞
η˜2(y − β˜τ,c − xTβ˜τ ,x)dµ(y).
Therefore, βτ,c + x
Tβτ = β˜τ,c + x
Tβ˜τ for all x. As a result, βτ,c = β˜τ,c, βτ = β˜τ , and
η2 = η˜2, which contradicts our assumptions.
Thus, we must have αc 6= α˜c. Without loss of generity, in the following, we assume
α˜c > αc.





1 + exp(α˜c + x
Tα1 + yα2)
1 + exp(αc + xTα1 + yα2)
(C.3)






1 + exp(α˜c + x
Tα1 + yα2)
1 + exp(αc + xTα1 + yα2)
×η1(x)η2(y − βτ,c − xTβτ ,x)dµ(y). (C.5)
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Taking the ratio of (C.4) and (C.5), using change of variable y = ǫτ +βτ,c+X






η2(y − βτ,c − xTβτ ,x)dµ(y)∫ 1+exp(α˜c+xTα1+yα2)
1+exp(αc+xTα1+yα2)














1 + exp(α˜c + x
Tα1 + yα2)





1− exp(α˜c − αc)
1 + exp(αc + xTα1 + yα2)
η2(ǫτ ,x)dµ(ǫτ )












Let βℓτ , β˜
ℓ
τ , and x
ℓ denote the ℓth element of βτ , β˜τ , and x, respectively, for ℓ = 1, · · · ,
dim(x). If there is ℓ such that β˜ℓτ − βℓτ > 0, then limxℓ→−∞ h1(x) = 0. Meanwhile, as
α˜c > αc, we have
h2(x) ≥
∫
η2(ǫτ ,x)dµ(ǫτ ) = 1.
Consequently, τ = 0, which contradicts the basic assumption on τ . Similary, if there
is ℓ such that β˜ℓτ − βℓτ < 0, letting xℓ →∞ will lead to the same conclusion, i.e., τ = 0.
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Let αℓ1 denote the ℓ








η2(ǫτ ,x)dµ(ǫτ ) and the denominator h2(x) → 1 as xℓ →
∞. Consequently, β˜τ,c − βτ,c = 0 according to the definition of the quantile regression
model. If there is ℓ such that αℓ1+β
ℓ
τα2 < 0, by letting x
ℓ → −∞, we obtain β˜τ,c−βτ,c = 0
as well.




















for all x. Let
c(ǫτ ,x) =
1 + exp{α˜c + βτ,cα2 + xT(α1 + βτα2) + ǫτα2}
1 + exp{αc + βτ,cα2 + xT(α1 + βτα2) + ǫτα2} .
If α2 > 0, then c(ǫτ ,x) is a strictly increasing function of ǫτ for all x. For all ǫτ < 0,
c(ǫτ ,x) < c(0,x), and for all ǫτ > 0, c(ǫτ ,x) > c(0,x), where c(0,x) = [1 + exp{α˜c +
βτ,cα2+x





c(ǫτ ,x)η2(ǫτ ,x)dµ(ǫτ ) < c(0,x)
∫ 0
−∞
η2(ǫτ ,x)dµ(ǫτ ) = τc(0,x),∫ ∞
0
c(ǫτ ,x)η2(ǫτ ,x)dµ(ǫτ ) > c(0,x)
∫ ∞
0
η2(ǫτ ,x)dµ(ǫτ ) = (1− τ)c(0,x).




c(ǫτ ,x)η2(ǫτ ,x)dµ(ǫτ )∫




c(ǫτ ,x)η2(ǫτ ,x)dµ(ǫτ )∫ 0
−∞
c(ǫτ ,x)η2(ǫτ ,x)dµ(ǫτ ) +
∫∞
0






c(ǫτ ,x)η2(ǫτ ,x)dµ(ǫτ )/
∫ 0
−∞
c(ǫτ ,x)η2(ǫτ ,x)dµ(ǫτ )
<
1
1 + (1− τ)/τ = τ,
which is impossible.
Similary, if α2 < 0, then c(ǫτ ,x) is a strictly decreasing function of ǫτ and similar






c(ǫτ ,x)η2(ǫτ ,x)dµ(ǫτ )/
∫ 0
−∞
c(ǫτ ,x)η2(ǫτ ,x)dµ(ǫτ )
>
1
1 + (1− τ)/τ = τ,
which is also impossible.
Hence, the problem is identifiable.
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C.2 Nonidentifiability when α2 = 0
Assume we have a parametric set {αc,α1,α2, βc,βτ , η1, η2}. Choose any α˜c with





π˜1 = 1− π˜0.
Note that π˜0 is the solution of exp(αc)π0/π1 = exp(α˜c)π˜0/(1− π˜0), Obviously, 0 < π˜0 <
1. Let
β˜τ,c = βτ,c,
β˜τ = βτ ,
α˜1 = α1,




1 + exp(α˜c + x
Tα1)
1 + exp(αc + xTα1)
η1(x).






1 + exp(α˜c + x
Tα1)





{π0 + exp(α˜c − αc)π1}




















It is clear that the parameter set {αc,α1,α2, βc,βτ , η1, η2} is different from the parameter
set {α˜c, α˜1, α˜2, β˜c, β˜τ , η˜1, η˜2}, while they both satisfy (C.1), hence the problem is not
identifiable.
C.3 Nonidentifiability of the Case α1 + βτα2 = 0
We first exclude the special case α2 = 0 for two reasons: (a) the nonidentifiability of
the case α2 has been proved in Section C.2, and (b) α2 here further implies α1 = 0, and
hence the case-control sampling is simply random sampling.
The nonidentifiability proof of the case α1 + βτα2 = 0 is similar to that of the case
α2 = 0. Assume we have a parameter set {αc,α1,α2, βc,βτ , η1, η2}. Choose any α˜c with
αc 6= α˜c and set π˜0, π˜1 identically as in the α2 = 0 case. Note that exp(αc)π0/π1 =
exp(α˜c)π˜0/π˜1.
Consider the special case when η2(ǫτ ,x) = η2(ǫτ ), i.e., the distribution of the quantile






1 + exp(α˜c + β˜τ,cα2 + α2ǫτ )
1 + exp(αc + β˜τ,cα2 + α2ǫτ )






1 + exp(α˜c + βτ,cα2 + α2ǫτ )
1 + exp(αc + βτ,cα2 + α2ǫτ )
η2(ǫτ )dµ(ǫτ ).








1 + exp(α˜c + βτ,cα2 + α2ǫτ )






1 + exp(α˜c + βτ,cα2 + α2ǫτ )





{π0 + exp(α˜c − αc)π1}
= π˜0 + π˜1 = 1,
as β˜τ,c →∞.
Set







1 + exp(α˜c + β˜τ,cα2 + α2ǫτ )
1 + exp(αc + β˜τ,cα2 + α2ǫτ )
η2(ǫτ + β˜τ,c − βτ,c),
where α˜c 6= αc and β˜τ,c is the solution of h3(β˜τ,c) = τ . It is easy to verify that η˜2(ǫτ ) is a
valid density function, π˜0 =
∫
η˜1(x)η˜2(ǫτ )/{1 + exp(α˜c + β˜τ,cα2 + α2ǫτ )}dµ(x)dµ(ǫτ ),
and η˜2 6= η2. Furthermore, the two parameter sets {αc,α1,α2, βc,βτ , η1, η2} and
{α˜c, α˜1, α˜2, β˜c, β˜τ , η˜1, η˜2} satisfy (C.1), hence the problem is not identifiable.
C.4 Nuisance Tangent Space Λ and its Orthogonal Complement Λ⊥
The nuisance tangent space Λ with nuisance parameter η = (η1, η2) is a subspace of
the Hilbert spaceH. It is defined as the mean squared closure of parametric submodel nui-
sance tangent spaces, where a parametric submodel nuisance tangent space with a finite-
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dimensional parameter γ = (γT1 ,γ
T
2 )
T is the set of all elements of the formWSγ . Here
W is an arbitrary p× q matrix with p = dim(θ) and q = dim(γ), and Sγ is the nuisance






−1∂η1(x;γ1)/∂γ1 − π−1d E{η1(x;γ1)−1∂η1(x;γ1)/∂γ1 | d},
Sγ2 = η2(ǫτ ,x;γ1)
−1∂η2(ǫτ ,x;γ2)/∂γ2
−π−1d E{η2(ǫτ ,x;γ1)−1∂η2(ǫτ ,x;γ2)/∂γ2 | d}.
η1(·) is an arbitrary density function, i.e., η1 ≥ 0 and
∫
η1(x)dµ(x) = 1, while η2(·,x) is
an arbitrary density function with τ th quantile zero, i.e., η2 ≥ 0,
∫
η2(ǫτ ,x)dµ(ǫτ ) = 1,
and
∫
uτη2(ǫτ ,x)dǫτ = 0. It is easy to show that show the nuisance tangent space Λ with
nuisance parameter η = (η1, η2) can be written as Λ = Λ1 ⊕ Λ2, where
Λ1 = [g(x)− E{g(X) | d} : g(x) ∈ Rp, Etrue{g(X)} = 0],
Λ2 = [g(ǫτ ,x)− E{g(ǫτ ,X) | d} : g(t,x) ∈ Rp, Etrue{g(ǫτ ,x) | x} = 0,
Etrue{uτg(ǫτ ,x) | x} = 0, a.s.].
We can further write
Λ = [g(ǫτ ,x)− E{g(ǫτ ,X) | d} : g ∈ Rp, Etrue(g) = 0,
Etrue{uτg(ǫτ ,x) | x} = 0, a.s.] .
130
For any h ∈ Rp, if h ∈ Λ⊥1 , then
0 = E(hT[g(X)− E{g(X) | D}])
= E({h− E(h | D)}T[g(X)− E{g(X) | D}])
= E[{h− E(h | D)}Tg(X)]
= E[E{h− E(h | D) | X}Tg(X)].
Therefore, E{h − E(h | D) | X}∑d ∫ fX,Y,D(x, y, d)dµ(y)/η1(x) = c a.s., for some
constant c. Notice that E[E{h− E(h | D) | X}] = 0, we further obtain
0 =
∫
E{h− E(h | D) | x}∑d ∫ fX,Y,D(x, y, d)dµ(y)dµ(x) = ∫ cη1(x)dµ(x) = c.
Hence, c = 0 and E{h− E(h | D) | x} = 0 a.s..
For any h ∈ Λ⊥1 , if h ∈ Λ⊥2 , then
0 = E(hT[g(ǫτ ,X)− E{g(ǫτ ,X) | D}])
= E({h− E(h | D)}T[g(ǫτ ,X)− E{g(ǫτ ,X) | D}])
= E[{h− E(h | D)}Tg(ǫτ ,X)]
= E[E{h− E(h | D) | ǫτ ,X}Tg(ǫτ ,X)].
Consequently,E{h−E(h | D) | ǫτ ,X}
∑
dfX,Y,D(X, Y, d)/{η1(X)η2(ǫ,X)} = uτa(X)+
c(X) a.s.. Since h ∈ Λ⊥1 , we have 0 = E{h − E(h | D) | X} = E[E{h − E(h | D) |
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ǫτ ,X} | X], a.s.. Thus,
0 =
∫
E{h− E(h | D) | ǫτ ,X}
∑










which implies c(X) = 0 a.s..
Furthermore, E{h − E(h | D) | ǫτ ,X}
∑
dfX,Y,D(X, Y, d)/{η1(X)η2(ǫτ ,X)} =
uτa(X) a.s., or equivalently,E{h−E(h | D) | ǫ,X}
∑
d(nd/n)H(d,X, Y )/πd = uτa(X)
a.s..
Hence,






= a(x)uτ , a.s. ∀a
]
.
C.5 Efficient Score Function Seff
We now derive the efficient score Seff through orthogonally decomposing Sθ into a
function in Λ and a function in Λ⊥.
We write Sθ = S−E(S | D) = g(ǫτ ,x)−E(g | D)+Seff , where Etrue(uτg | x) = 0.
We alternatively write Seff = S− g(ǫτ ,x)− E(S− g | D) and Seff satisfies






and E(Seff) = 0. However, E(Seff | d) = 0 automatically, hence we can ignore the second
requirement E(Seff) = 0. The property E(Seff | d) = 0 also simplies the first requirement
132
to













= E(S− g | ǫτ ,x)− E {E(S− g | D) | ǫτ ,x} .
From our model (4.3), we have



















To simplify notation, in the following calculation we denote
b0 = E{fD|X,Y (1,X, Y ) | D = 0};
b1 = E{fD|X,Y (0,X, Y ) | D = 1};
c0 = E(S | D = 0)− E{E(S | ǫτ ,X) | D = 0};






u0 = E {uτa(X)κ(X, Y ) | D = 0} ;
u1 = E {uτa(X)κ(X, Y ) | D = 1} ;
v0 = E(S− g | D = 0);
v1 = E(S− g | D = 1).
Note that π0 + π1 = 1, b0n0 = b1n1, c0n0 + c1n1 = 0 and v0π0 + v1π1 = 0.
Under a true model, π0, π1, b0, b1, c0, c1 are known quantities, while u0,u1,v0,v1 are
not known because g = g(ǫτ ,x) and a = a(x) are not specified. To further obtain
u0,u1,v0,v1, we rewrite
uτa(x)κ(x, y) = E(S− g | ǫτ ,x)− v0fD|X,Y (0,x, y)− v1fD|X,Y (1,x, y)
= E(S | ǫτ ,x)− g − v0fD|X,Y (0,x, y)− v1fD|X,Y (1,x, y).
as
g(ǫτ ,x) = E(S | ǫτ ,x)− uτa(x)κ(x, y)− v0fD|X,Y (0,x, y)− v1fD|X,Y (1,x, y). (C.9)
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Since v0 = E(S− g | D = 0), we obtain
v0 = E(S | D = 0)− E
{
E(S | ǫτ ,x)− uτa(x)κ(x, Y )
−v0fD|X,Y (0,x, Y )− v1fD|X,Y (1,x, Y ) | D = 0
}
= c0 + u0 + v0(1− b0) + v1b0.
Thus, we have b0v0− b0v1−u0 = c0. Similarly, from v1 = E(S−g | D = 1), we obtain
v1 = E(S | D = 1)− E
{
E(S | ǫτ ,x)− ǫτa(x)κ(x, Y )
−v0fD|X,Y (0,x, Y )− v1fD|X,Y (1,x, Y ) | D = 1
}
= c1 + u1 + v0b1 + v1(1− b1).
Thus, we have −b1v0 + b1v1 − u1 = c1. Since
E {uτa(x)κ(x, Y )} = 0,
we have
u0n0 + u1n1 = 0.
Combining the above relations, we have obtained n0u0 + n1u1 = 0, π0v0 + π1v1 = 0,
b0v0− b0v1−u0 = c0 and−b1v0+ b1v1−u1 = c1. The last two equations are equivalent
so one is redundant. Using these relations, we can rewrite u1,v0,v1 as a function of u0:
u1 = −(n0/n1)u0, v0 = (π1/b0)(u0 + c0), v1 = −(π0/b0)(u0 + c0). (C.10)
We cannot obtain a more explicit expression for u0 at this stage, but we can further obtain
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a(x) as a function of u0. Using (C.9) and since Etrue(uτg | x) = 0, we have
Etrue {uτE(S | ǫτ ,x) | x} − Etrue
{





uτfD|X,Y (0,x, Y ) | x






u2τκ(x, Y ) | x
}]−1
[
Etrue {uτE(S | ǫτ ,x) | x} − v0Etrue
{










u2τκ(x, Y ) | x
}]−1 [
Etrue {uτE(S | ǫτ ,x) | x}
−(π1/b0)(u0 + c0)Etrue
{




uτfD|X,Y (1,x, Y ) | x
}]
.





u2τκ(x, Y ) | x
}]−1
; (C.11)
t2(x) = Etrue {uτE(S | ǫτ ,x) | x} − (π1/b0)c0Etrue
{




uτfD|X,Y (1,x, Y ) | x
}
= Etrue {uτE(S | ǫτ ,x) | x} − (c0/b0)Etrue
{


















a(x) = t1(x){t2(x) + t3(x)u0}, (C.12)
hence the definition of u0 yields
u0 = E (uτ [t1(x){t2(x) + t3(x)u0}]κ(x, Y ) | D = 0)
= E {uτ t1(x)t2(x)κ(x, Y ) | D = 0}+ E {uτ t1(x)t3(x)κ(x, Y ) | D = 0}u0.
This yields
u0 = [1− E {uτ t1(x)t3(x)κ(x, Y ) | D = 0}]−1 (C.13)
×E {uτ t1(x)t2(x)κ(x, Y ) | D = 0} . (C.14)
Combining the above results, we have obtained the analytic form of Seff = S−g−E(S−
g | D = d), where g is given in (C.9), a(x) is given in (C.12), v0,v1 are given in (C.10)
u0 is given in (C.13) and the functions t1, t2, t3 are given in (C.11).
In forming the estimating equation
∑N
i=1Seff = 0, we will have
∑N
i=1{S(xi, Yi, Di)−
g(Yi − xTi βτ ,xi)} − n0E(S− g | D = 0)− n1E(S− g | D = 1) = 0. Using (C.9), we
obtain
E(S− g | D = 0) = E(S | D = 0)− E{E(S | ǫτ ,x) | D = 0}
+E{uτa(x)κ(x, Y ) | D = 0}
+v0E{fD|X,Y (0,x, Y ) | D = 0}
+v1E{fD|X,Y (1,x, Y ) | D = 0}
= c0 + u0 + v0(1− b0) + v1b0
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and
E(S− g | D = 1) = E(S | D = 1)− E{E(S | ǫτ ,x) | D = 1}
+E{uτa(x)κ(x, Y ) | D = 1}
+v0E{fD|X,Y (0,x, Y ) | D = 1}
+v1E{fD|X,Y (1,x, Y ) | D = 1}
= c1 + u1 + v0b1 + v1(1− b1),
hence
n0E(S− g | D = 0) + n1E(S− g | D = 1)
= n0{c0 + u0 + v0(1− b0) + v1b0}+ n1{c1 + u1 + v0b1 + v1(1− b1)}
= (n0c0 + n1c1) + (n0u0 + n1u1) + (n0v0 + n1v1) + (v1 − v0)(n0b0 − n1b1)
= n0v0 + n1v1.
Thus, the estimating equation simplifies to
∑N
i=1{S(Xi, Yi, Di)− g(Yi −XTi βτ ,Xi)} − n0v0 − n1v1 = 0.
C.6 Proof of Theorem 4
Proof: For simplicity of proof, we split the n observations randomly into two sets. The
first set contains n − n1−δ observations and the second set contains n1−δ observations,
where 0 < δ < (1/2 − dτ) is a small positive number. We form and solve the estimating
equation using data in the first set, while calculating all the hatted quantities described in
the algorithm in Section 4.4 using data in the second set. We use this only as a technical
device, although in our simulations and empirical example we used all the data.
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In the algorithm, the approximations involve either replacing expectation with aver-
aging or standard kernel regression estimation, hence the differences between the quan-
tities with hat and without hat have either mean zero, standard deviation O(n−(1−δ)/2),
or mean O(hr), standard deviation O{(n1−δhd)−1/2}. In particular, Ŝ∗eff(Di,Xi, Yi,θ0) −
S∗eff(Di,Xi, Yi,θ0) has bias O(h
r) and standard deviation O{(n1−δhd)−1/2}. Thus,



































Ŝ∗eff(Di,Xi, Yi,θ0)− S∗eff(Di,Xi, Yi,θ0)
}
+ op(1).
We see that Ŝ∗eff(Di,Xi, Yi,θ0) differs from S
∗
eff(Di,Xi, Yi,θ0) in that all the unknown
quantities, except S∗, are estimated. This is equivalent to estimating the unknown func-


















∂S∗eff(Di,Xi, Yi,θ0, η0)/∂η}(η̂ − η0) (C.15)
+Op{(n− n1−δ)1/2(η̂ − η0)2}+ op(1), (C.16)
where ∂S∗eff(Di,Xi, Yi,θ0, η0)/∂η is pathwise derivative. However, S
∗
eff is the projection














= −E{S∗eff(Di,Xi, Yi,θ0, γ)STγ } = 0.
The last equality is because by definition Sγ ∈ Λwhich is orthogonal to Λ⊥ and S∗eff ∈ Λ⊥.
Here, fX,Y,D(x, y, d) is defined in (4.3). Because γ is parameter of any arbitrary submodel
of η, we actually have obtained
E{∂S∗eff(Di,Xi, Yi,θ0, η0)/∂η} = −E{S∗eff(Di,Xi, Yi,θ0, η0)STη } = 0,
where Sη is the nuisance score function along the arbitrarily chosen specific path of
the pathwise derivative. Thus, the first term of (C.15) is of order op(1). On the other
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hand, Op{(n − n1−δ)1/2(η̂ − η0)2} = Op{n1/2h2r + n1/2(n1−δhd)−1} = Op(n1/2−2rτ +
n−1/2+δ+dτ ) = op(1). We therefore obtain









(n− n1−δ)1/2(θ̂ − θ0) + op(1).
This yields (n− n1−δ)1/2(θ̂ − θ0)→ Normal{0,A−1B(A−1)T}, and hence
n1/2(θ̂ − θ0)→ Normal{0,A−1B(A−1)T}
when n→∞.
141
